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Abstract 
This aim of this thesis was to explore experiences of emotional distress and sleep-wake 
patterns in an acute stroke rehabilitation setting.  Both the systematic review and research 
paper are being prepared for submission to the international Journal of Stroke; the guidelines 
of which are included in the appendices (Appendix D, paper 1).  
Paper one is a systematic review of the literature investigating the potential benefit 
of third-wave psychological therapies to support individuals experiencing emotional distress 
resulting from previous stroke. Ten papers were reviewed and included in a narrative 
synthesis. The quality of the methodology of the studies is evaluated and discussed.  Third-
wave interventions offer some promising initial results; however, research in this area is in 
its infancy, and requires further investigation.  
The research paper (paper two) explored the relationship between sleep, mood and 
pain and the possible predictive value these variables have on participation in rehabilitation.  
Experience sampling methods and actigraphy were utilised in this study. Twenty 
participants were recruited and took part in the study for an average of seven days.  A multi-
level model analysis was used to explore the data.  Results indicate that sleep efficiency, low 
mood and pain all offer some predictive value for participation in rehabilitation in this 
sample.   
Paper three is a critical appraisal of the systematic review and research paper. 
Pertinent issues, relevant to both papers are discussed.  Recommendations for future 
research as well as considerations for clinical implications are discussed within the context 
of the research findings.   
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Abstract 
Background and Purpose - A clear link between stroke and experiences of emotional 
distress has been established in extant literature. Recent studies have demonstrated an 
association between emotional distress and functional recovery of the stroke survivor.   
Supporting patients to manage distress by equipping them with skills and coping strategies 
may represent an important intervention for increasing the quality of life experienced by 
stroke-survivors.  Third-wave interventions comprise those that encourage an individual to 
have compassion for and acceptance of their present moment, or difficulty, rather than 
attempting to change it.  These interventions have become increasingly common in physical 
health settings, and evidence suggests they can be of significant benefit to patients. 
However, there has been no systematic examination of the effects of third-wave 
interventions on emotional distress within a stroke population.  This review aims to evaluate 
the effects and possible benefits of these interventions in a post-stroke context.  
Methods -  Seven databases were searched using key words.  Papers were screened using 
review specific criteria. Critical appraisal was conducted independently by two reviewers. 
Data extraction was conducted by the lead author, findings are presented in narrative form. 
Results- Ten studies involving 284 participants were reviewed. Five papers reported third-
wave interventions on a one-to-one basis and four were group format. The results 
demonstrate a positive trend in favour of the benefits of third-wave interventions supporting 
to reduce the level of emotional distress experienced by the individuals after stroke.  
Conclusions- Following stroke, individuals experiences of emotional distress may be 
reduced by engagement with third-wave therapies. However, further methodologically 
robust research is required to determine the effectiveness of these third-wave interventions. 
Key words: ▪third-wave interventions, ▪emotional distress, ▪mood, ▪stroke, ▪rehabilitation. 
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Introduction  
Emotional distress following stroke is common. Estimates suggest around a quarter 
of stroke survivors experience anxiety 1 and one third of survivors’ experience depression, in 
the three years following their stroke 2. Emotional distress can impede rehabilitation 
activities as well as functional recovery 3. Yet, currently, evidence remains limited for 
effective management of emotional distress in the stroke population, with both 
psychotherapeutic and pharmacological interventions demonstrating limited success 4. 
Emerging psychology research has suggested that third-wave psychological interventions 
can be beneficial and useful to patients experiencing both physical and psychological 
distress 5. However, there has been no systematic examination of the effects of third-wave 
psychological interventions on emotional distress, in the stroke population.   
Stroke 
Stroke occurs suddenly, often without warning, and can result in significant distress 
and disability 6.   Medical developments and improved public awareness in the recognition 
and treatment of stroke have resulted in an increase in survival rates 7, with approximately 
two-thirds of the estimated 152,000 people who experience stroke each year in the United 
Kingdom (UK) surviving 8.  Alongside medical advances, much attention has been paid to 
improving public longer-term support of individuals who experience stroke, and their 
families 9-11.  Although these initiatives have offered people who experience stroke 
improved survival rates and care, stroke remains one of the main causes of adult disability in 
the UK 12.  Physical and communication impairments are among the most recognisable 
deficits following stroke 13.  However, there are a significant number of stroke survivors 
who experience a range of less visible impairments such as post stroke fatigue 14, pain 15, 
cognitive difficulties 16, behavioural problems 17 and issues with mood and emotional 
distress 18.  As a result, people may experience difficulties caring for themselves or living 
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independently 19, as well as problems with social activities and relationships 20.  These 
difficulties can have a significant impact on the lives of stroke survivors and their families. 
 Epidemiological data suggests there are more than 1.1 million stroke survivors 
living in the UK alone 21, with more than half of these survivors being dependent on others 
for support with everyday activities 9.  The incidence rate of stroke is much higher in older 
adults, with stroke in the over 65-year-old population accounting for three quarters of the 
total stroke incidence 8.  Given the ageing nature of the population 22, the incidence of stroke 
is likely to increase, as is the number of people requiring post-stroke support.  
Emotional distress following stroke 
 
Depression and anxiety.  Stroke can have a considerable impact on psychological 
wellbeing 23 with 10.6-31.1% of people experiencing post-stroke depression (PSD) and / or 
post stroke anxiety (PSA) 24.   PSD can be defined as the prolonged (over two weeks) 
experience of sadness or worry, associated with a lack of energy and changes in sleep. PSA 
is understood as feelings of anxiety or worry that do not rescind when the stressful situation 
is over or feeling anxious for no reason 1, 25. Both PSD and PSA map onto the diagnostic 
criteria of depression and anxiety respectively as defined by Diagnostic and Statistical 
Manual DSM-V; 26 and International Classification of Disease ICD-10; 27.  Research posits 
that both immediately following stroke, as well as in the longer term 28 PSD is linked with: 
lower functional status 29, poorer rehabilitation outcomes 30, increased rates of mortality 31, 
and as a reduced quality of life 32.   In addition, longitudinal data suggests that both 
depression 33 and anxiety1 can remain a difficulty for survivors of stroke many years after 
stroke incidence 1.   
Emotional/ psychological distress.  The experience of stoke can be incredibly 
distressing for the individual and can contribute to a range of negative emotions that are not 
THIRD WAVE THERAPIES AND POST STROKE DISTRESS                                                                        1—5  
captured by the diagnostic classification of anxiety or depression 34.  Instead, these tend to be 
captured under the umbrella terms “psychological distress” and/or “emotional distress” 18.  
These umbrella terms are often used interchangeably in literature, however, for the purposes 
of this paper the term emotional distress will be used. The empirical evidence base suggests 
that these terms are used to describe a range of experiences. These include, but are not 
limited to:  anger, frustration, stress, fear of further stroke, helplessness, apathy, feeling 
socially isolated, and grief 34-36. These types of difficulties tend to be overlooked by research 
in favour of more commonly used diagnostic disorders of mood. One possible explanation 
for this is that there are fewer validated measures with which to assess general psychological 
distress. However, many survivors of stroke do not meet diagnostic threshold or 
classification, but still experience significant psychological impairment which in turn 
contributes to poor post-stroke adjustment 37 and quality of life 32.   
Psychological Interventions 
 
Psychological interventions in health settings are designed to support people who are 
experiencing distress related to their physical health condition 38. One way in which they 
might do this is to support people with their adjustment to living with the effects of their life 
long and, at times, life limiting conditions.  
Cognitive behavioural therapy (CBT) is the most common evidence based 
psychological treatment option for mood difficulties post-stroke 39, 40.  CBT is a talking 
therapy that supports individuals to identify unhelpful thoughts and behaviours that may be 
linked with their experiences of distress, with the primary aim of overall symptom 
reduction.  Despite the popularity of CBT based interventions, therapeutic outcomes for 
survivors of stroke are varied with studies reporting small effect sizes 41-43.  One suggestion 
as to why there has been limited success with CBT style interventions is that they require 
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individuals to monitor and control their thoughts and feelings as a way of reducing 
symptoms of anxiety and depression.  For a stroke survivor with cognitive and/or 
communication difficulties these internal strategies may be challenging, due to problems 
with attention, memory, language or executive functioning 44.  In addition, each time they 
are asked to complete an activity that relies on their cognitive skills, it may act as a reminder 
of the consequences of their stroke 45.  Struggling with tasks that previously would not have 
presented as difficult may in itself be distressing for the individual. Furthermore, the thought 
challenging aspects of CBT can be particularly problematic in the context of actual physical 
losses.  The utility of thought challenging is based on the assumption that the unhelpful 
thought is a cognitive distortion, which can be resolved and replaced with a more logical 
thought. However, if the troublesome thoughts are based on facts such as experiences of 
functional losses following accident or injury, this traditional CBT approach may not be as 
effective.   Consequently, CBT style interventions may not be an effective intervention for 
everyone 44 and may have limited longer-term success 46. 
Third-wave therapies are described as those that encompass aspects of compassion 
for, and acceptance of, negative internal sensations and thoughts, rather than engaging in a 
process of trying to change them 47.  Although, there remains differing perspectives on 
which psychological approaches should be categorised as third-wave interventions 48, it is 
generally accepted by experts in the field 49 that a number of therapeutic interventions could 
be classed as third-wave: Acceptance and Commitment Therapy ACT; 50, Compassionate 
Mind Therapy  CMT; 51, Compassion Focused Therapy CFT; 52, Mindfulness Based 
Cognitive Therapy MBCT; 53, Mindfulness Based Stress Reduction MBSR; 54, Dialectical 
Behaviour Therapy DBT; 55, and Extended Behavioural Activation 56. Extended behavioural 
activation is increasingly regarded as a third-wave approach as it has an explicit focus on 
shifting attention away from depressive ruminative thoughts 49.   Third-wave approaches 
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adopt a position in which the aim is to improve quality of life of the individual rather than 
focusing on a reduction in symptoms of distress. In this sense, these interventions are often 
trans-diagnostic 57 in nature and more readily adapted to suit different cognitive and 
communication needs58. For a comprehensive discussion of specifics of these third-wave 
interventions please see Dimidjian and colleague (2016) 59. 
Previous reviews have sought to examine the effects of interventions on depression 
and anxiety post-stroke. In their review, Cole and colleagues (2001) 60 included 
pharmacological interventions only, whilst recent Cochrane reviews 41, 61 focused on the 
effects of both pharmacological and non third-wave psychotherapeutic interventions. 
Although there has been a review of mindfulness interventions in this area, the authors 
solely included mindfulness interventions and did not evaluate other third-wave approaches 
62.  Therefore, to date, there has been no systematic review examining the effects of third-
wave intervention on the range of the emotional difficulties experienced by survivors of 
stroke.  
The Present Systematic Review 
 
The primary aim of this review was to (a) assess the effectiveness of available RCT 
studies based on the Cochrane criteria, and (b) to consolidate the available knowledge and 
offer recommendations for future clinical practice and future research. In their qualitative 
study regarding patients’ experiences of psychological distress following stroke, Crowe et 
al, (2016) 34, found that participants spoke of issues of self-compassion and acceptance, 
which suggests that third-wave psychological therapies could be well placed to address the 
difficulties experienced by survivors of stroke. 
Effectiveness/efficacy will be assessed in those studies which meet the current UK 
and Cochrane recommendations 63, 64 for conducting intervention reviews, which includes 
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both randomised controlled trials (RCTs) and non-randomised controlled studies (non-
RCT’s).  Effectiveness will be defined as a statistically significant improvement in 
emotional distress, compared with a control group as demonstrated under controlled 
conditions in an RCT. Efficacy will be defined by the same change identified in studies 
which have lower internal validity but have higher ecological validity, such as case control 
studies based in hospitals and clinics 63.   
Available knowledge will be consolidated and recommendations for future clinical 
practice and research will be made.  This review will have implications for public health and 




This systematic review followed guidance from the Preferred Reporting Items for 
Systematic Reviews and Meta-Analyses (PRISMA) statement for conducting and reporting 
systematic reviews 66, 67.   
Identification of Studies  
 
 All eligible studies were identified by searching seven electronic databases including 
MEDLINE, EMBASE, psycINFO, CINHAL, Scopus, Academic Search Complete and 
PsycArticles.  All databases were searched on 22nd January 2018.  Databases were searched 
using terms associated with stroke, emotional distress and third-wave psychological 
interventions, which can be found in Table 1.    
In addition, bibliographies of previous reviews and retrieved search articles were 
hand-searched to identify further relevant articles not included in the search material.   
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Insert Table 1 
Inclusion and Exclusion Criteria 
 
The aim of the search strategy was to locate all published articles in relation to 
experiences of emotional distress following stroke and any subsequent interventions using 
third-wave therapies.  All studies require publication in a peer reviewed journal to be included 
in the analysis, allowing for a pre-determined quality control standard. The relevance of each 
study was assessed using the inclusion criteria which is stated in Table 2.  
Studies were excluded from the review if they were: (a) unpublished articles; theses 
or dissertations; abstracts; posters; (b) qualitative studies; (c) non-third-wave interventions 
such as traditional CBT.  The author screened all titles and abstracts highlighted from the 
searches for their suitability in the review.  Following this, full-text articles considered 
relevant to the review were retrieved.    
Insert Table 2 
Risk of Bias 
 
In accordance with PRISMA guidance, this review evaluated the quality and strength 
of each included study in order to determine how much confidence could be placed on the 
overall findings.  The overall strength of the evidence presented in each study, assessed as 
strong, moderate or weak, was determined using the Quality Assessment Tool for Quantitative 
Studies 68 developed by the Effective Public Health Practice Project (EPHPP - See Appendix 
A).  This tool was selected based on its reliability in examining the effectiveness of 
interventions 69.  In addition, the tool allowed examination of a range of study designs which 
were reflected in the included papers of this review.  The tool adopted a component method 
of evaluation, considering six domains: selection bias; study design; confounders; blinding; 
data collection method and; withdrawals and dropouts.  Each domain was assigned a strong, 
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moderate or weak rating and these collected ratings were used to establish the global rating 
for each study.  The tool also allowed space to consider intervention integrity and analyses 
choice when rating each study. 
Data Extraction 
 
 Data, including details of the type of third-wave intervention and target population, 
were extracted from the included studies using a data extraction tool which was designed by 
the author (see Appendix B).  The form was pilot tested for suitability using three randomly 
selected studies and was amended accordingly.  This information is presented in the 
summary table which includes study, participant, intervention characteristics and outcome 
measures, as well as outcome and findings (see Table 4).   
 Data Synthesis 
When considering the included studies for data synthesis, a high degree of 
heterogeneity was observed, with differences noted in study design, length of intervention 
and outcome measurement.   This indicated that pooling the data for a meta-analysis would 
not be suitable. As such, a narrative synthesis was conducted in line with Cochrane 
principles 70.  
Quality Assessment 
 
 Quality assessment was completed using the pre-selected quality assessment tool for 
quantitative studies (see Table 3).  The author’s reasons for each quality judgement can be 
found in Appendix C.  
 Insert Figure 1  
 
 




See Figure 1 for a flow diagram of the search results. Following the removal of 
duplicates a total of 594 articles were identified.  Of the 594 articles identified, 561 were 
excluded based on their titles and abstracts. The remaining 33 articles were read in full and 
assessed for eligibility. Twenty-three articles were excluded based on the reasons outlined in 
Figure 1.  A total of ten articles were included in this review. Data for stroke participants 
from two papers were gathered by contacting authors for copies of the study data.  
Insert Table 3 
Quality Assessment  
 
Study quality is outlined in Table 3. Two of the studies received a rating of ‘strong’ 
71, 72; a further two were awarded a rating of ‘moderate’ 73, 74; the final six studies received a 
rating of ‘weak’ 75-80.  
Insert Table 4 
Study characteristics   
 
Three of the studies were conducted in the UK 71, 76, 77, two studies were conducted 
in Sweden 73, 74, and one study took place in each of the following: Korea 78, United States 
of America (USA) 72, Canada 75, New Zealand 79 and Australia 80. There was an equal mix 
of group and one-to-one interventions. Studies included were published between 2005 and 
2017 and used a range of study designs. Two of the studies were randomised controlled 
trials 71, 72, a further two studies utilised a controlled clinical trial design, 73, 74, and all of 
these studies used demographically matched treatment as usual control groups.  Three 
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studies were cohort design 77, 78, 81. The final three of the included studies were case studies 
76, 79, 80.   
Participant’s characteristics  
 
Participants were adults with an age range of 25-88 years. There was a total of 284 
participants across all ten included studies. The ratio of male and female participants was 
reported in nine of the studies with Johansson et al, (2015) 73 not reporting this information, 
which related to 16 participants. Across the remaining nine studies, males accounted for 
57% of the total participants while female participants made up 43% of the total. Type of 
stroke was recorded in five of the ten studies 72, 77-79 with ischaemic stroke being the most 
prevalent. Lateralisation of the deficit was noted in four of the studies 71, 77, 79 with left sided 
deficit being reported most often. The number of participants taking antidepressant 
medication was reported in two of the studies 71, 79, and features as an exclusion criterion in 
one study 78.  All studies reported that participants experienced clinical levels of emotional 
distress as measured by tools such as the Hospital Anxiety and Depression Scale HADS; 82 
and the Beck Depression Inventory BDI; 83.  
Intervention characteristics   
 
There were a range of third-wave psychological interventions included in this 
review. The majority of studies were based on mindfulness principles (n= 6). MBSR 
accounted for five of these studies 73, 77-79, 84.  The remaining study 81 was an MBCT 
intervention and specific adaptations were made to physical yoga elements of the 
intervention to be accessible to the participant population. This study also included a 
psychoeducation element that was specific to the stroke population.  Two 71, 72 of the 
included studies followed an extended behavioural intervention.  One study 72 permitted 
family members to be present during the intervention session.  The final two studies 76, 80 
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used an ACT 50 and a CFT 52 based intervention respectively.  The number of sessions 
(range 4-20) and total intervention hours (range 8- 20) varied across all studies.   
Outcome characteristics  
 
The aim of this review was to consider the impact of third-wave psychological 
interventions on emotional distress as a general concept, which would include a range of 
presentations as mentioned above. However, studies included in this review all used 
outcome measures that exclusively focused on concepts of depression and anxiety.  For the 
purpose of this section we will refer to anxiety and depression as ‘mood’.     
Eight studies employed reliable and validated measures of mood, which were 
normed within a stroke population and measured anxiety and depression either separately or 
jointly. A range of mood measures were used across the included studies: two studies 73, 74 
used the Comprehensive Psychopathological Rating Scale-CPRS 85; two 78, 81 utilised the 
Beck Anxiety Inventory as well as the Beck Depression Inventory-BAI; BDI 83; and two 77, 
81 collected information on mood using the Hospital Anxiety and Depression Scale- HADS 
82. A further two studies 76, 80 employed the short form Depression and Anxiety Stress Scale- 
DASS-21 86, The Hamilton Rating Scale for Depression-HRSD 87, the Visual Analogue 
Mood Scale-VAMS 88 ‘sad’ item, and the Stroke Aphasic Depression Questionnaire SADQ 
89 were each used once across the included studies. One further study 79 utilised the BAI 90, 
which had not been normed for this population.  Finally, Joo et al. (2010) 78 choose to 
measure participants distress using the State Trait Anxiety Inventory-STAI 91, which does 
not have a demonstrable validity for stroke populations 92.  In addition to the STAI, Joo and 
colleagues (2010) 78 used the Korean version of the BDI 93.  All but one of the studies 
reported the measured score means and standard deviations for pre and post intervention 
assessment. Merriman et al. (2015) 77 reported that there was a demonstrable improvement 
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in mood as measured by the HADS for three of the four participants, but did not report mean 
or standard deviation data, nor did they run any statistical analysis.  Outcomes other than 
those considering emotional distress were not the focus of this review and as such were not 
included in the matrix.   
Effectiveness of third-wave psychological interventions   
 
Four controlled studies, two RCTs 71, 72, and two non-RCT 73, 84 were included in this 
review. Given that information on stroke participants was extracted from the wider studies 
in the two non-RCT studies, the sample size was small and it was not possible to consider 
the results of the stroke on participants at a statistical level.  Consequently, only two RCT 
studies were assessed in terms of the effectiveness of third-wave interventions. The RCT 
samples were classified as experiencing clinical levels of depression as measured by the 
diagnostically validated scales noted above. Both RCTs reported significant improvement in 
emotional distress on the intervention arm compared with the control group; however, both 
studies demonstrated small effect sizes. Both RCTs examined the impact of extended 
behavioural intervention on depression as measured by validated self-report tools. Both 
studies reported significant results indicating that behavioural therapy was successful at 
reducing the rates of depression in the study sample which were maintained at 6 months 71 
and 24 months 72 follow up.  Both of the interventions were conducted on a one-to-one basis 
and participants were welcome to bring a family member or carer along to the sessions, 
although this option was not regularly taken up by participants. In both studies the average 
number of sessions was nine, although one study offered a maximum of 20 sessions 71.  In 
both cases, the number of sessions was determined by the therapist who for all participants 
deemed that 20 sessions were not needed.  
Summary of cohort and case studies    
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While data from cohort and case studies were not included in the appraising of the 
effectiveness of third-wave interventions, these were examined for findings that were 
relevant to both future research and clinical practice. All non RCT studies provided evidence 
that third-wave interventions had a positive and in one case 81, lasting effect on the 
experience of low mood. Two of the cohort studies that investigated mindfulness-based 
interventions 78, 81 were able to demonstrate significant results in the comparison of pre and 
post assessments of mood difficulties, as was a case-study looking at the impact of CFT 80. 
This indicates that engaging in the third-wave intervention approaches can have a positive 
impact in reducing experiences of emotional distress. Two of the case studies indicated a 
positive impact of third-wave interventions, including a case series with four participants 
completing a mindfulness intervention 77, and a case-study with one participant engaging in 
ACT  76. However, as these studies included no statistical analysis, it was difficult to draw 
accurate conclusions of the effects of the intervention. One case-study 79, of an individual 
with mood difficulties following stroke reported a significant reduction in anxiety following 




This literature review demonstrated that experiences of emotional distress following 
stroke is an active research area.  Third-wave interventions showed some promising positive 
results.  The aims of this systematic review were to (a) assess the effectiveness of available 
RCT studies based on the Cochrane criteria, (b) to consolidate the available knowledge and 
offer recommendations for future clinical practice and future research. 
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Effectiveness of Third-Wave Psychological Therapies 
 
 The primary aim of third-wave interventions is to support individuals with their 
adjustment to life as it is now, through methods of acceptance and compassion 94.  A 
reduction in the experience of mood difficulties is often a by-product of the intervention 
rather than the primary focus. However, there remains a lack of validated and well-
established measures that assess this construct of moving towards acceptance of a new life 
95.  Consequently, the studies included in this review have used measures of mood, which 
are symptom reduction based, as their primary outcome measures. As such these are the 
measures which this review is required to consider in terms of intervention success.    
 Both RCTs included in this review used behavioural interventions and reported an 
overall improvement in depression, which was sustained at 6 months 71 and 24 months 72 
follow up. Additionally, both studies reported that participants experienced positive changes 
in leisure and recreation engagement. A further strength of these studies is that they used 
validated measures of depression that were appropriate for the stroke population. Both 
studies included participants with varied severity of low mood, with the mean mood score 
for both studies being in the mild to moderate range. This is an encouraging finding, as it 
appears that the interventions were both useful and acceptable to participants across a range 
of experiences. However, further research may want to consider the impact of these 
interventions with people with more severe experiences of low mood and anxiety, as it is 
often these individuals who are in most in need of support.  
A further strength is that one of these studies 71 included participants who 
experienced a range of communication difficulties.  Empirical findings postulate that the 
incidence of emotional distress following stroke is more prevalent in people with aphasia, 
being around 60% compared with 30% non-aphasic stroke survivors 96. Additionally, 
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research has suggested that there is a positive correlation between severity of aphasia and 
experiences of depression 97. Despite this, people with aphasia are often excluded from 
stroke research due to the methodological and practical difficulties associated with their 
recruitment into studies 98. The inclusion of this group suggests that third-wave behavioural 
interventions are practical and beneficial for people experiencing communication difficulties.   
When considering these results within the context of the National Institute of Clinical 
Excellence (NICE) recommended CBT treatment for post-stroke mood difficulties, they 
represent similar findings. Specifically, significant improvements can be demonstrated but 
that effect sizes remain small 41.  The limited number of controlled trials reflects the 
emerging status of third-wave therapies in this area as well as current difficulties conducting 
RCTs with a post-stroke population.   
Effects of Third-Wave Psychological Therapies 
 
 All eight non RCT studies indicated a positive impact of third-wave therapies on 
emotional/psychological distress in the post stroke population. Six of the studies used a 
validated measure of mood within the stroke population to establish an intervention effect. 
Although two 73, 74 studies reported significant positive results for the intervention, these 
were conducted within the context of the wider brain injury participant population. 
Therefore, inferences based on the included stroke participants alone cannot be made. When 
interpreting the results of the non-RCTs included, there are a number of methodological 
issues that need to be taken into consideration. Firstly, three of the studies were case studies 
76, 79, and as such, these results need to be interpreted with caution. Although all of these 
studies indicated positive results for the three participants involved, it is possible that these 
results may not be replicated on a larger scale. While the findings of these studies are 
promising, it is important to note that the lack of a control group in six of these studies 
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means that it cannot be determined whether the change demonstrated is as a direct result of 
the intervention.   Furthermore, in all of the case studies the participant had a pre-existing 
clinical relationship with the therapist, meaning that there was increased opportunity to 
develop a therapeutic rapport, which has been shown to be associated with the success of an 
intervention irrespective of the therapeutic modality 99, 100.  
Generalisability of Findings 
 
All of the non-clinical studies included in this review received a rating of ‘weak’ in 
terms of controlling for selection bias.  It could be argued, however, that the heterogeneous 
nature of the participants included in the studies reflects a reasonable level of external 
validity. They included a wide range of participants, including both community and hospital 
samples that would be representative of the range of individuals who may present to services 
looking for support with emotional distress following stroke. The high degree of diversity 
among the participants provides a strong basis for generalising the conclusions drawn on the 
effects of third-wave therapies.  The variety of the locations where the studies were 
conducted provides further strength to the generalisability of the findings. Furthermore, the 
collective participant ratio for gender appears to reflect extant literature which has found that 
males are more likely to experience a stroke 101.  Although the studies in this review 
represent a good range of countries, the impact of cultural or ethnic influences are not 
considered in any of the studies.  It may be that the effects of these third-wave interventions 
are impacted by cultural factors as are other psychological therapies 102, and further research 
in this area is required.  
 Furthermore, there are two studies included in this review 71, 79 that specifically 
looked at the impact of third-wave therapies on emotional distress in people with aphasia. 
Both studies demonstrated a positive impact of their respective interventions, ACT 79 and 
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extended behavioural therapy 71.  This is a positive finding considering that individuals who 
experience communication difficulties often experience increased emotional distress 103.  
However, it is important to note that neither study considered those individuals who 
experience severe aphasia, and further research is required to establish if third-wave 
interventions are feasible and acceptable for this group. Furthermore, only one of the studies 
included in this review specifically recruited a participant who experiences cognitive 
difficulties following stroke.  Research indicates that individuals who experience cognitive 
difficulties following stroke not only experience greater rates of emotional distress 104, but 
they are often excluded from research due to methodological and ecological limitations 
relating to challenges in communication and possible issues with capacity to consent 105.  
Interpreting Findings Alongside Previous Research 
 
 Taken together the included studies provide an early indication that third-wave 
therapies can have a positive impact on the experience of emotional difficulties within the 
post-stroke population. Findings from previous literature indicate that one of the driving 
factors for the experience of emotional difficulties post-stroke is the difficulty in adjusting to 
life following the event, where the individual may be experiencing both physical and 
cognitive deficits 106, 107.  It has been suggested that individuals who experience less 
emotional distress have a higher level of acceptance of their ‘new’ life post-stroke 108. This 
positive association of acceptance and lower levels of distress post-stroke is one possible 
reason for the success of the third-wave interventions.  It may be that learning to accept 
emotional experiences within the present moment may allow individuals to more readily 
adjust to their level of functioning post-stroke.  As such, it is possible that the included 
studies theoretically map onto the concept of successfully adjusting to the new life and 
living well post-stroke.  
THIRD WAVE THERAPIES AND POST STROKE DISTRESS                                                                        1—20  
The inclusion of some participants who experience communication deficits indicates 
that third-wave approaches may be more acceptable and accessible to a wider range of 
individuals who experience stroke, than cognitive based approaches which rely on higher 
level of cognitive functioning 109.   
Strengths and Limitations of Included Studies 
 
 One strength of the studies included in this review is that the range of attrition was  
0-16%, This is favourable compared with other psychological interventions with this client 
group, where rates are typically in the region of between 2-22% 110. One possible reason for 
this lower attrition could be the inclusion of several case studies and case series designs.  
Moreover, many interventions in this review contained elements of active outreach where 
the intervention took place in the participants home, which routinely demonstrates lower 
attrition rates.   Furthermore, one study 72, did not have a predetermined number of sessions 
for completion.  Instead the study had a maximum number of sessions available for 
participants (up to 20), meaning that there was no clear way to measure the completion rates 
of the intervention, and as such we are unable to establish what the optimum number of 
sessions would be, in terms of both adherence to treatment as well as impact of intervention.
  A number of studies included participants who self-selected to take part. This may 
have led to a sample of participants who were especially motivated to participate, or who 
held positive beliefs about the nature of third-wave interventions.   There was also a lack of 
reporting on participant selection in the case series and case study research included in this 
review.  It is therefore possible that researchers may have selected participants that they 
believed would engage well with third-wave interventions, or that they may have only 
reported case studies that reflected a positive result for the intervention.  
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The risk of bias due to confounding effects was also widespread, which is 
unsurprising as case series and cohort designs are particularly susceptible to such errors. 
Confounding variables for this population can include a history of pre-morbid emotional 
difficulties, aphasia, and cognitive deficits, as well co-morbid physical health difficulties 111.  
These variables were not routinely reported, or controlled for, in the included studies.   
Further to this, none of the included studies differentiated their participants based on 
location of lesion, which has been shown to have an impact of post stroke mood difficulties 
and could have a possible impact on an individual’s ability to learn and retain new 
information 112. In addition, many included studies did not consider of the possible impact of 
either specific antidepressant medication, or other medication which may either contribute to 
or alleviate experiences of emotional distress.  This makes the mechanism of change more 
difficult to determine.  
Publication bias had limited impact on the included studies as they are predominately 
case series, case study and cohort design, which engender less possibility of publication bias 
that RCT research.  However, all of the studies reported a positive impact of their respective 
intervention methods. As publication of non-significant or negatively correlated results are 
limited 113, it is not possible to attest that publication bias did not play a role in the studies 
included in this review.  
It is also important to note that not all of the studies included in this review used 
outcome measures that have been validated for a stroke population. As such, it cannot be 
ascertained that the studies were able to measure the emotional distress that they intended to 
and so results from these studies must be interpreted with caution. Furthermore, all of the 
included studies measured emotional distress on the diagnostic constructs of anxiety and 
depression.  Therefore, conclusions cannot be drawn on effects of third-wave intervention 
across the spectrum of emotional experiences.  As noted above, the primary goal of third-
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wave interventions is to support individuals to adjust to their ‘new’ life post-stroke, however 
none of the studies in this review use this adjustment measure as their primary outcome.  
There is a need for future researchers to establish the validity and reliability of assessments 
that successfully measure this construct.    
Strengths and Limitations of the Review Process 
 
One strength of this review is that overall it has attempted to follow as closely as 
possible the PRISMA guidelines 67, which resulted in a transparent, comprehensive and 
replicable review.  
 A limitation of this review is that it was conducted by a single author. This could 
have had an impact at a number of stages, such as database searching, data extraction and 
quality assessment; however, this draw back was mediated by the process of supervision that 
occurred throughout the review process.  The chosen quality assessment tool relied heavily 
on a subjective assessment of each component, which has been argued to impact its 
reliability 114. In an effort to counter this, the lead author sought consultation from other 
researchers on the quality assessment of the included studies, and an inter-rater reliability of 
80% was reached. 
 While the inclusion of only peer reviewed literature in this review was necessary to 
maintain quality standards, it is possible that this has limited the inclusion of some novel 
research in this area with two unpublished doctoral theses having to be excluded. There is 
some evidence from medical research that posits that the exclusion of such “grey literature” 
can result in an overestimation of an interventions effectiveness 115 due to bias towards the 
publication of positive results.  Additionally, the exclusion of articles published in a 
language other than English can impact on the reliability of evidence as it has been 
demonstrated that studies with negative or non-significant results often publish in non-
THIRD WAVE THERAPIES AND POST STROKE DISTRESS                                                                        1—23  
English journals 116.  However, taking the above points into consideration when reflecting 
on this review process, there is a reasonable level of surety that this review provides a 
comprehensive overview of the current published peer-reviewed evidence base.  
Recommendations for Future Research and Clinical Practice 
 
 Despite the recent increase in publications considering the impact of third-wave 
therapies on emotional and psychological distress following stroke, case studies and cohort 
studies form a significant proportion of the evidence base. While these studies provide 
important preliminary insight into the use of third-wave interventions within this population, 
they carry little weight in terms of developing a robust evidence base for the effectiveness of 
a therapeutic intervention that might influence national guidelines, such as those published 
by NICE (2013) and Royal College of Psychiatry (RCP; 2016) 9, 117.  This review highlights 
the requirement for more focus on the emotional and psychological needs of people post-
stroke.  Further funding in this area is required as to allow researchers in this field to publish 
high-quality controlled research. Moreover, conducting more standardised research using 
reliable and validated measures of distress such as the SADQ 118 and the VAMS 119 as well 
as interventions that are more consistent in length would allow for an easier comparison 
against other interventions.  
 There remains a significant gap in the research into the identification of emotional 
distress following stroke, whereby currently individual experiences of distress are quantified 
using the diagnostic categories of anxiety and depression. With measures that divide human 
experiences into these categorical narratives, there is a risk of missing other problematic 
experiences of distress such as anger, frustration, and hopelessness. Further development of 
a clinically valid tool which measures the spectrum of emotional experiences within this 
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clinical population would facilitate the identification of individuals who may benefit from 
psychological interventions.  
Future research should focus on those individuals who currently do not benefit from 
or do not complete current recommended interventions 117, to determine if third-wave 
interventions may be a more suitable therapeutic model. Moreover, given that third-wave 
therapies focus on improving quality of life rather than aiming to reduce symptoms, future 
research should consider utilising measures which consider quality of life and psychological 
functioning, similar to those which have been utilised in one of the included studies 120.   
 Some of the studies included in this review demonstrate that third-wave therapies 
can be effective at reducing distress in as little as four sessions.  Moreover, there is evidence 
that third-wave interventions can be effective in a group setting which would provide further 
cost effectiveness from a health service perspective. Shorter, more cost-effective 
interventions are beneficial to services, service users and carers as they will positively 
impact on waiting list times as well as the cost-effective provision of services. Furthermore, 
as third-wave interventions do not focus specifically on the reduction of symptoms, they can 
be considered trans-diagnostic in nature, indicating that they have the potential to offer 
useful interventions across the spectrum of emotional distress.   
 There is an increasing need for research to include participants from harder to reach 
groups such as those with communication and/or cognitive difficulties. Third-wave therapies 
have demonstrated success with these groups within other populations 121, 122.  Further 
research should consider the feasibility and acceptability of third-wave interventions for 
people who have additional communication and cognitive needs.   
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Conclusions 
 
 Based on the studies included in this review, the research provides some promising, 
evidence for the effects of third-wave interventions and their usefulness and feasibility in a 
post-stroke population.  Due to methodological limitations, however there is currently a 
scarcity of robust evidence to support the utility and effectiveness of third-wave therapies in 
the context of emotional distress. There is a requirement for further research into this area 
and consequently, clinicians wishing to adopt third-wave approaches should do so in the 
context of clinical research, with the aim of contributing to the evidence base.   
  A potential area for future research could focus on the development of validated and 
reliable measures of the spectrum of emotional distress. Furthermore, there is scope to 
develop measures considering issues of adjustment and quality of life for stroke survivors, 
and not merely symptom reduction.  Despite the ongoing need for effective interventions to 
support people who experience emotional distress following stroke, the lack of RCTs 
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Table 1   
Database Search terms. 
  
Search Domain Search Terms 
Stroke (cerebral or cerebellar or brain* or vertebrobasilar) AND 
(infarct* or ischeami* or thrombo* or emboli* or apoplexy) OR 
(cerebral or intracerebral or intracranial or brain) AND 
(haemorrhage or haemorrhage or bleed*) OR cerebrovascular 
disorders OR (stroke* or poststroke* or cva*) OR 
(cerebrovascular* or cerebral vascular)   
Emotional Distress emotional distress OR psychological distress OR anxiety OR 
depress* OR posttraumatic stress OR PTSD OR psychological 
morbidity OR psych* OR adjustment OR emotional adjustment 
OR mood OR adjustment disorder OR acute stress disorder OR 
fear of relapse OR Depression* OR involutional* or Depressive 
disorder* or Dysthymic disorder* OR dysthymi*  
Third-Wave Psychological 
Interventions 
"behavio* activation" OR "Compassion focussed therapy" OR 
"compassionate Mind training" OR "Dialectical behavio* 
therapy" OR "mindfulness based stress reduction" OR "MBSR" 
OR "mindfulness based cognitive therapy" OR "MBCT" OR 
"acceptance and commitment therapy" OR "Metacognitive 
therapy" OR “MCT” 
Note: “ACT” was not used as a search term as it resulted in erroneous studies being retrieved 
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Table 2.  
Inclusion Criteria  
Inclusion Criteria 
Population Individuals over the age of 18 who had experienced a stroke and resulting 
emotional distress. A broad definition of stroke was adopted to include 
ischaemic stroke, haemorrhagic stroke, subarachnoid haemorrhage, and 
transient ischemic attack (TIA) and mixed populations where stroke data could 
be extracted. The review considered studies which measured levels of 
emotional distress using either questionnaire-based tools or structured clinical 
interview assessment.  
Intervention Individuals received an intervention that was classified as a third-wave 
psychological therapy as detailed above; both individual and group 
interventions were included 
Comparator Both studies with and without a comparison group or intervention were 
included 
Setting Community, or hospital. 
Study design All treatment study designs were included to ensure a comprehensive review of 
existing literature, taking into account the current availability of published 
literature on third-wave interventions and the lack of RCT’s.   
Outcomes 
 
At least one quantitative outcome measure was required, either self or other 
report relating to emotional distress following stroke.  Outcome measures were 
reported pre- or post-intervention or over the course of the intervention 
Publication All studies had to be published in a peer reviewed journal and written or 
translated into English and were published and available any time prior to and 
including 22nd January 2018. 
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Table 3 











Moustgaard, Bedard, Felteau (2004) 
Canada 
 
Moderate Moderate Strong Weak Strong Strong Moderate 
 




Moderate Weak Strong Weak Weak Strong Weak 




Moderate Moderate Strong Weak Strong Strong Weak 
Joo, Lee, Chung, & Shin (2010) 
Korea 
 
Moderate moderate Moderate Weak Moderate Weak Weak 
Dickinson, Friary, McCann (2016) 
New Zealand 
 
Moderate Weak Strong Weak Weak Strong Weak 
Mitchell, Veith, Becker, Buzaitis, Cain, 




Strong Strong Strong Strong Strong Strong Strong 







Strong Strong Strong Moderate Strong Strong Strong 
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Table 4 






Sample Size/ population 
characteristics 














30 participants who had 
experienced a stroke over 
the age of 30yrs with 23 
completers. 23% attrition.    
A community-based sample. 
Male =6, female= 17. 
included both aphasia (n=2) 
and non-aphasia participants 
(n=21) Nature of stroke not 
noted. Lateralisation: Right 
(n=11), Left (n=12).  
Antidepressant:  not 
reported.  
 
MBCT - with adaptations to the yoga 
elements in line with the physical needs 
of the sample. Psychoeducation specific 
to stroke was also included. Focus of 
treatment was to reduce experiences of 
depression but was extended to include 
other aspects of emotional and physical 
coping.  Duration and frequency: 9 
weekly sessions that were 1.45 hr long. 
Facilitators: A 3rd year clinical 
psychology trainee and a certified 
mindfulness and yoga instructor. 











Significant reduction of 
depressive symptoms (p < 
.001) and anxiety (p.001).  
Measured by both the HADS 
and BDI/BAI, large effect sizes 
of between 0.42-0.64 were 
reported.  Reductions were 








Case Study - 
pre and post 
measures 
 
Sample Size: 1 male 
participant, 40yrs, non-
aphasia, who was 
experiencing anxiety 
following a stroke. 
Antidepressant: not 
reported.  
ACT intervention. Duration and 
frequency: 9 sessions, duration and 
frequency of sessions is not reported. 
Format: one to one. Facilitator: 1 
trainee clinical psychologist under 







Improvements in both 
depression and anxiety at end 
of treatment as well as at 2 
months follow up as measured 
by the DASS-21.  No details of 
statistical analysis  
 






Sample Size/ population 
characteristics 









Case series - 




Sample size: Community 
sample of 4 participants who 
had experienced a stroke.  
Age range of 47-62, all 
participants were between 
1-4 years post stoke. Side of 
deficit: 3 participants right 
sided ischaemic stroke, 1 
participant left sided 
ischaemic stroke. Gender: 
Three males and one female. 
Antidepressant: not 
reported.  
Mindfulness group- MBSR. Duration and 
frequency: 9 Sessions, lasting for 2 
hours each week. Participants were also 
required to engage with home tasks. 
Format: group.  Facilitor: one clinical 







Reductions in the scores for 
anxiety and depression at end 
of treatment for three of the 
four participants, no statistical 
analysis conducted and no 













Sample size: 28 community-
based participants who 
experienced stroke, and 
mood difficulties. Age range 
38-65 Attrition: 39%. 
Gender: 5 males and 6 
females. All participants 
experienced a cerebral 
aneurysm rupture. 
Antidepressants: Participants 
using psychiatric drugs were 
excluded.  
MBSR intervention.  Duration and 
frequency: an eight-week programme 
with a 2.5hr sessions once per week, in 
addition participants were expected to 
complete home-based tasks. Format: 
Group.  Facilitator: not reported.  
 
Beck depression 
inventory - Korean 




A significant difference was 
shown in the depression 
scores for patients (p=.013). A 
borderline statistically 
significant result was 
demonstrated for the 
reduction of anxiety both 
state and trait (p=.091 and 
p=.056). No follow period 
reported.  
 






Sample Size/ population 
characteristics 








Case Study - 
pre and post 
measures 
 
Sample Size: 1 female 
participant 59 years of age, 
who was 3 years post stroke 
and experiencing severe 





Mindfulness intervention.  Duration and 
frequency: 4-week course of weekly 
sessions last 90-120mins, the 
participant was also required to 
complete a home-based mindfulness 
exercise 5 times per week between the 
sessions. Format: one to one. 
Facilitator: a clinical psychologist who is 
also a trained MBSR practitioner 
Beck Anxiety 
Inventory (BAI)  
 
Significant reduction in anxiety 
both immediately following 
intervention and at 3 weeks 





















Sample Size: 101 - 53 control 
and 48 intervention, all 
participants were recruited 
within 4 months of 
experiencing an ischaemic 
stroke Gender: male 61, 
female 40, mean age was 57 
with a range of 25-88. 
Attrition: 9% 
Antidepressants:  60.4% of 
the intervention, and 64% of 
control group were taking 
antidepressants. 
Psycho social behavioural intervention.  
Durations and frequency: 9 sessions 
over an 8-week period. Format: one to 
one, participants could opt to have a 
family member present. Facilitator: 












Significant reduction in 
depression: 9 weeks (p<.001, 
CI= -8.2 - -4.0), 21 weeks 
(p=0.98, CI= -4.8-0.4), 12 
months (p=.023, CI= -5.4—
0.4), 24 months (p=.108, CI= -
4.9-0.5) 
 






Sample Size/ population 
characteristics 











Sample size: 105 - 54 usual 
care, 51 intervention, 
participants who had 
experienced stroke with 
aphasia and who were 
identified as experiencing 
low mood. Gender: 63% 
male participants.  Location: 
12 participants were hospital 
based and 93 were 
community based.  Side of 
deficit: left (n=72), Right 
(n=8), Bilateral (3), unknown 
(n=22). Attrition: 15% 
Antidepressants: 29 
participants were taking 
antidepressants.  
Extended behavioural therapy. Duration 
and frequency: up to 20 1hour sessions 
over a 3 months period. Facilitator: 
delivered by an assistant psychologist 
supervised by a clinical psychologist. 





the VAMS 'sad' 
item.  
 
Significant reduction in 
depression. 3months adjusted 
for baseline communication 
score:  SADQH (p=.20; CI= 
7.81-0.01) and at 6 months 
without the need for 
adjustment of communication 
measures (p=.002, CI= -9.95—
2.30). VAMS (sad item) 
3months (p=.033, CI= -22.30- -














Sample size: 12 Stroke N.B. 
22 in sample; 10 traumatic 
brain injury. Intervention 
group: Mean age in 
MBSR1=54.1, Waitlist group: 
control = 56.9. Gender: there 
were 12 females and 9 
males.  Type of stroke and 
lateralisation not noted, nor 
MBSR group programme.  Duration and 
frequency: 8 weekly, 2.5 hour, sessions, 
one day-long silent retreat between 
session 6 and 7, as well as home tasks 
of 45min 6 days per week.  Format: 
Group.  Facilitator: profession of 




Rating Scale (CPRS) 




Depression and anxiety were 
secondary outcome measures 
in this study as its primary aim 
was to look at fatigue. From 
the extracted data on stroke 
only participants a downward 
trend in both anxiety and 
depression is exhibited for 
both the active treatment 






Sample Size/ population 
characteristics 











is aphasia. time since stroke 
is 3-10 years. 
Antidepressants: Participants 
using mediation including 
antidepressants were not 
excluded from the study, 
although numbers were not 
reported. Attrition: 23% 
 
group while mood remains 
























Sample size: 16 stroke 
participants, N.B. 34 in total, 
18 traumatic brain injury. 
Stroke participants: f2f = 5, 
internet =5, walking control 
= 6. Mean age: f2f=42.6, 
internet= 47, walking=55.83. 
Antidepressant: not 
reported. Attrition: 11% for 
overall study although it is 
unclear how many of stroke 
participants completed the 
intervention.  
 
MBSR group programme.  Duration and 
frequency: 8-weekly 2.5-hour session 
MBSR programme. Format: Group.  










Rating Scale (CPRS) 








Reduction in both depression 
and anxiety scores as 
measured by the CPRS 
following the 8-week 
programme. As this data was 
extracted from a wider brain 
injury study it is not possible 
to comment on the level of 
significance. Although in the 
overall study there was a 
significant reduction in the 
overall scores of anxiety and 
depression.  
 






Sample Size/ population 
characteristics 











One female participant, aged 
48, who had experienced a 
cerebral aneurysm with left 
sided deficit 18 months 
previously, and was 
currently experiencing 





Compassion focussed therapy (CFT) in 
addition to cognitive rehabilitation. 
Duration and frequency: ten weekly 
sessions, length of session not reported.  
Facilitator: clinical psychologist.    
 
Depression Anxiety 
Scale (DASS-21).  
 
Reliable change indices (RIC): 
which measure the efficacy of 
an intervention based on pre 
and post measures 
demonstrated significant 
positive change (p< 0.05). 
DASS-21 scores were no 
longer in the clinical range.  
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Figure 1. PRISMA flow diagram. 
Note: PRISMA= Preferred Reporting for Systematic Reviews and Meta-Analyses.    
A = 123-125, B = 126-140, C = 141, 142, D =143, 144, E = 145.  
 
Records identified through 
database searching  





















n Additional records identified 
through other sources  
(n = 8) 
Records after duplicates removed  
(n = 594) 
Records screened  
(n = 594) 
Records excluded  
(n = 561) 
Full-text articles 
assessed for eligibility  
(n = 33) 
Full-text articles 
excluded, with reasons  
(n = 23) 








E: Unable to extract 
stroke related data (n=1) 
Studies included in 
quantitative synthesis  
(n = 10) 




QUALITY ASSESSMENT TOOL FOR QUANTITATIVE STUDIES 
COMPONENT RATINGS  
A) SELECTION BIAS  
(Q1) Are the individuals selected to participate in the study likely to be representative of the target population?  
Very likely  
Somewhat likely  
Not likely  
Can’t tell  
 
(Q2) What percentage of selected individuals agreed to participate?  
80 - 100% agreement  
60 – 79% agreement  
less than 60% agreement  
Not applicable  
Can’t tell  
RATE THIS SECTION  STRONG  MODERATE  WEAK  
See dictionary  1  2  3  
 
 B) STUDY DESIGN  
Indicate the study design  
Randomized controlled trial  
Controlled clinical trial  
Cohort analytic (two group pre + post)  
Case-control  
Cohort (one group pre + post (before and after))  
Interrupted time series  
Other specify ____________________________  
Can’t tell  
 
Was the study described as randomized? If NO, go to Component C.  
No Yes  
If Yes, was the method of randomization described? (See dictionary)  
No Yes  
If Yes, was the method appropriate? (See dictionary)  
No Yes RATE THIS SECTION  STRONG  MODERATE  WEAK  
See dictionary  1  2  3  
C) CONFOUNDERS  
(Q1) Were there important differences between groups prior to the intervention?  
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Yes  
No  
Can’t tell  
 
The following are examples of confounders:  
Race  
Sex  
Marital status/family  
Age  
SES (income or class)  
Education  
Health status  
Pre-intervention score on outcome measure  
 
(Q2) If yes, indicate the percentage of relevant confounders that were controlled (either in the design (e.g. 
stratification, matching) or analysis)?  
80 – 100% (most)  
60 – 79% (some)  
Less than 60% (few or none)  
Can’t Tell  
RATE THIS SECTION  STRONG  MODERATE  WEAK  
See dictionary  1  2  3  
D) BLINDING  
(Q1) Was (were) the outcome assessor(s) aware of the intervention or exposure status of participants?  
Yes  
No  
Can’t tell  
 
(Q2) Were the study participants aware of the research question?  
Yes  
No  
Can’t tell  
RATE THIS SECTION  STRONG  MODERATE  WEAK  
See dictionary  1  2  3  
E) DATA COLLECTION METHODS  
(Q1) Were data collection tools shown to be valid?  
Yes  
No  
Can’t tell  
 
(Q2) Were data collection tools shown to be reliable?  
Yes  
No  
Can’t tell  
RATE THIS SECTION  STRONG  MODERATE  WEAK  
See dictionary  1  2  3  
F) WITHDRAWALS AND DROP-OUTS  
(Q1) Were withdrawals and drop-outs reported in terms of numbers and/or reasons per group?  
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Yes  
No  
Can’t tell  
Not Applicable (i.e. one time surveys or interviews)  
 
(Q2) Indicate the percentage of participants completing the study. (If the percentage differs by groups, record the 
lowest).  
80 -100%  
60 - 79%  
less than 60%  
Can’t tell  
Not Applicable (i.e. Retrospective case-control)  
 
RATE THIS SECTION  STRONG  MODERATE  WEAK  
See dictionary  1  2  3  Not Applicable  
G) INTERVENTION INTEGRITY  
(Q1) What percentage of participants received the allocated intervention or exposure of interest?  
80 -100%  
60 - 79%  
less than 60%  
Can’t tell  
 
(Q2) Was the consistency of the intervention measured?  
Yes  
No  
Can’t tell  
 
(Q3) Is it likely that subjects received an unintended intervention (contamination or co-intervention) that may 
influence the results?  
Yes  
No  
Can’t tell  
 
H) ANALYSES 
(Q1) Indicate the unit of allocation (circle one)  
community organization/institution practice/office individual  
(Q2) Indicate the unit of analysis (circle one)  
community organization/institution practice/office individual  
(Q3) Are the statistical methods appropriate for the study design?  
Yes  
No  
Can’t tell  
 
(Q4) Is the analysis performed by intervention allocation status (i.e. intention to treat) rather than the actual 
intervention received?  
Yes  
No  
Can’t tell  
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GLOBAL RATING  
COMPONENT RATINGS  
Please transcribe the information from 
the gray boxes on pages 1-4 onto this 
page. See dictionary on how to rate 
this section. A  
SELECTION 
BIAS  
STRONG  MODERATE  WEAK  
1  2  3  
B  STUDY DESIGN  STRONG  MODERATE  WEAK  
1  2  3  
C  CONFOUNDER
S  
STRONG  MODERATE  WEAK  
1  2  3  
D  BLINDING  STRONG  MODERATE  WEAK  
1  2  3  
E  DATA 
COLLECTION 
METHOD  
STRONG  MODERATE  WEAK  




STRONG  MODERATE  WEAK  
1  2  3  Not Applicable  
GLOBAL RATING FOR THIS PAPER (circle one):  
1 STRONG (no WEAK ratings)  
2 MODERATE (one WEAK rating)  
3 WEAK (two or more WEAK ratings)  
With both reviewers discussing the ratings:  
Is there a discrepancy between the two reviewers with respect to the component (A-F) ratings?  
No Yes  
If yes, indicate the reason for the discrepancy  
1 Oversight  
2 Differences in interpretation of criteria  
3 Differences in interpretation of study  
Final decision of both reviewers (circle one): 1 STRONG  
2 MODERATE  
3 WEAK  
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Appendix B     Data Extraction Tool. 
 
Study When intervention conducted Country Setting Commercial research supported Study design 
            
























                            
Mean Age Gender Ethnicity 
Type of 
Stroke 
Medication Side of Deficit Inclusion / Exclusion Intervention credibility 
                
Outcomes             Conclusions 
                
THIRD WAVE THERAPIES AND POST STROKE DISTRESS                                                                        1—59  
Appendix C 
 Judgements of Quality Assessment.  
 
Quality Assessment for Moustgaard et al. (2005) 75. 
Component Judgement  Rating 
Selection Bias The individuals taking part in the research are likely to be representative of the population – however participants 
were self-selected from poster advertisements – so results should be viewed with caution.  
Moderate 
Study Design This was not a randomised design – however it was experimental in that participants mood was measured pre and 
post intervention.  
Moderate  
Confounders This study included participants who were representative of the target population – however they did exclude 
participants who experienced severe cognitive impairment.  
Strong 
Blinding This was not an RCT – both the researchers and the participants were clear about the aims of the study.  Weak  
Data Collection 
Methods 
Used reliable and validated measures of emotional distress for a stroke population.  Strong  
Withdrawals and 
dropouts 
A 23% attrition rate was reported, as well as reasons for drop out.  Completers did not differ from drop outs.  Strong 
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Judgement of Quality for Graham et al. (2015) 76.  
Component Judgement  Rating 
Selection Bias The participant involved in this study is likely to be representative of the target population, however this participant 
had been referred to psychotherapy – and was undergoing treatment as part of usual care. The participant may 
have been more open to the support of psychology than the target population as a whole.  
Moderate 
Study Design Case study Weak  
Confounders The participant was not being compared with another individual, only with their own outcomes, pre and post 
intervention.  
Strong  





This study did not use a valid or reliable measure for a stroke population, so the outcomes can not be assessed in 




As this was a case study there were no drop outs.  Strong  
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Judgement of Quality for Merriman et al. (2015) 77. 
Component Judgement  Rating 
Selection Bias The participants are likely to be representative of the target population, however they were all recruited from a 
support group of people who were already accessing support for stoke related difficulties. It is also unclear if 
participants knew one another, and if so this may have impacted on the group dynamics of the intervention.  In 
addition, no inclusion or exclusion criteria were reported.  
Moderate  
Study Design This study opted for a cohort design and measured participants mood pre and post intervention.  Moderate  
Confounders These participants are likely to be representative of the target population. Details of type of stroke, location and 
ongoing difficulties reported.  
Strong  
Blinding Both the participants and the researchers were aware of the research questions.  Weak  
Data Collection 
Methods 
This study used a validated and reliable tool for the stroke population to measure participant emotional distress.  Strong  
Withdrawals and 
dropouts 
There were no drop outs in this study.  Strong  
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Judgement of Quality for Joo et al. (2010) 78.  
Component Judgement  Rating 
Selection Bias The participants in this study were recruited from a hospital sample and were likely to be representative of the 
target population in terms of stroke related difficulties. However, the study considered patients who had 
experienced an aneurysmal subarachnoid haemorrhage which account for only 5% of all strokes.  
Moderate  
Study Design This was cohort design with per and post measures of mood.  Moderate  
Confounders This study although did not report inclusion and exclusion criteria, and only considered participants who 
experienced a specific type of stroke. However, this may represent to some extent the target population.  
Moderate  
Blinding Both the researchers and the participants were aware of the research question.  Weak 
Data Collection 
Methods 
This study used a combination of measures to look at experiences of emotional distress, the measure of depression 




There was a very high attrition rate for this study 61%, no details are provided for the group differences between 
drop outs and completers.  
Weak  
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Judgement of Quality for Dickinson et al. (2016) 79.  
Component Judgement  Rating 
Selection Bias The participant in this study is typical of the target population in terms of experiences of distress following stroke. It 
is important to note that the participant was self-selected and as such may be more open to psychological 
intervention that the typical population.  
Moderate 
Study Design The is a case study Weak 
Confounders The participant in the study, was typical of the target population and was not excluded from the research due to 
difficulties with communication, which is unusual in stoke research.  
Strong 
Blinding Both the researcher and the participant were aware of the research aims.  Weak  
Data Collection 
Methods 
This study is not utilise a validated and reliable measure of mood for a stroke population.  Weak 
Withdrawals and 
dropouts 
There were no drop outs – case study design.  Strong 
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Judgement of Quality for Mitchell et al. (2009) 72.  
Component Judgement  Rating 
Selection Bias The participants were reprehensive of this population, all having experienced a stroke and being identified by 
clinical interview as having difficulties with mood post-stroke.  
Strong 
Study Design RCT – computer generated randomisation, groups matched by severity of stroke and severity of depression.  Strong 
Confounders Participants were not excluded due to cognitive or physical difficulties, and Barthel index was reported.  Strong 
Blinding All outcome assessors were blinded to the group allocation of the participants at each assessment stage.  Strong 
Data Collection 
Methods 
This study used a validated and reliable measure of mood for the stroke population.  Strong 
Withdrawals and 
dropouts 
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Judgement of Quality for Thomas et al. (2013) 71.  
Component Judgement  Rating 
Selection Bias Participants are reprehensive of the target population, recruitment took place in hospital and community setting as 
well as community groups.  
Strong 
Study Design RCT  Strong 
Confounders Study controlled well for confounding effects – individuals who were currently undergoing treatment for depression 
were excluded from the study.  
Strong 
Blinding Participants were not aware of group allocation, although it is unclear if researchers who were collecting outcome 




This study used reliable and validated measures of mood for a stroke population.  Strong 
Withdrawals and 
dropouts 
There was a 19% attrition rate for this study, drop outs did not differ from the completers.  Strong 
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Judgement of Quality for Johansson et al. (2012) 74. 
Component Judgement  Rating 
Selection Bias This study included participants who are representative of the population, however participants were self-selected 
from a newspaper advertisement.  The study also excluded participants who have any cognitive deficits, although 
participants who were taking medication were permitted to take part.  
Moderate 
Study Design This was a controlled trial, it states that the participants were randomised to groups, however does not give details 
of the procedure for this. It also adopted a design, whereby the control group are then after a waiting time offered 
the intervention and this is then analysis as intervention group 2.  
Strong 
Confounders The groups in this study were matched for age and disability, they are representative of a stroke population.  Strong 
Blinding It is not clear how the participants were randomised to the study, it is also not clear from the study if the 




This study used a measure of mood that has received some evidence for the stroke population, however the 




The attrition rate for this study was 24%, reasons for drop out were reported.  Participants dropped out the study 
namely due to issues of ill health and cognitive impairment, as such they represent a difference from the completer 
group.  
Moderate 
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Judgement of Quality for Johansson et al. (2015) 73.  
Component Judgement  Rating 
Selection Bias This study included participants who are representative of the population, however participants were self-selected 
from a newspaper advertisement.  The study also excluded participants who have any cognitive deficits, although 
participants who were taking medication were permitted to take part. 
Mod 
Study Design This study was a controlled trial, with a waitlist control group, participants were able to select to be part of either 
the face to face or the internet group for the MBSR delivery.  
Strong 
Confounders Groups were matched in terms of time since injury, age and gender, and type of injury, stroke or TBI.  Strong 
Blinding It is not clear if the researchers were aware of which group the participants belonged to when they were 




This study used a measure of mood that has received some evidence for the stroke population, however the 




Attrition rates are not reported in this study, however it is not possible to establish how many of the participants 
who experienced stroke may have completed the intervention.  
Moderate 
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Judgement of Quality for Shield & Ownsworth (2013) 80.  
Component Judgement  Rating 
Selection Bias The participant involved in this study is likely to be representative of the target population, however this participant 
was referred initially for neuropsychology testing and anxiety was identify as an issue.  As such following the neuro 
assessment and support the participant may have been more open to the support of psychology than the target 
population as a whole.  
Moderate  
Study Design Case study Weak  
Confounders The participant was not being compared with another individual, only with their own outcomes, pre and post 
intervention.  
Strong  





The study used the DASS-21 validated for measuring anxiety in post-stroke population Strong 
Withdrawals and 
dropouts 
As this was a case study there were no drop outs.  Strong  
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Appendix D 
Submission Guidelines (notes for authors) - Stroke.  
 
New Submissions 
To submit your manuscript online, please visit the journal's online manuscript submission 
site (http://stroke-submit.aha-journals.org), and follow the instructions for creating an author 
account and submitting a manuscript. Access can also be gained by visiting Stroke online 
at http://stroke.ahajournals.org and selecting the Online Submissions button. If you have any 
questions about the online submission process, contact the Editorial Office by e-mail 
at stroke@strokeahajournal.org. 
Initial Review Process 
Submitted manuscripts will be evaluated initially by an associate editor or guest editor. During 
initial review, the associate editor will determine whether or not the manuscript is appropriate for 
a full review based on the quality, originality, scientific rigor and data presentation/analysis of the 
manuscript. In some instances, the associate editor may reach out to a second reviewer 
(assistant editor, section editor, member of the editorial board, or invited reviewer with topic-
related expertise) for this quick assessment. It is anticipated that approximately 50% of the 
submitted manuscripts will undergo formal review and 50% will be rejected without evaluation by 
external reviewers. This policy reflects the stringent requirements for the acceptance of 
manuscripts submitted to Stroke. 
Expedited Publication 
The editors invite submission of manuscripts that have major importance to the scientific 
community. To be considered for expedited publication, an article must be unique and contain 
information that could make a significant difference in medical practice or constitute an important 
advance in basic knowledge. The authors must clearly state reasons for the request in the cover 
letter. If the editors agree that an article should be an expedited publication, they will arrange an 
accelerated review and, if accepted, accelerated publication. 
Guest Editors 
To avoid actual or perceived conflict of interest, the journal uses guest editors to handle certain 
manuscripts. For more details, see the Conflict-of-Interest Policy. 
Cover Letter 
Please upload a cover letter that includes the following statement: “All authors have read and 
approved the submitted manuscript, the manuscript has not been submitted elsewhere nor 
published elsewhere in whole or in part, except as an abstract (if relevant).” The cover letter may 
include the names of up to 3 potential reviewers whom the authors would like to suggest, 
especially members of the editorial board. The authors may also include the names of up to 3 
reviewers whom they would like to not evaluate their submission. The editor ultimately decides 
who reviews the manuscript. Lastly, please note any potential overlapping content submitted or 
accepted to another journal or conference. 
Manuscript Formatting 
• Only Microsoft Word files will be accepted for review. 
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• Manuscripts must be double-spaced, including references, figure legends, and tables. 
• We recommend using Times New Roman 12-point font. 
• Leave 1-inch margins on all sides. Number every page, beginning with the abstract page, 
including tables, figure legends, and figures. 
• Manuscripts should be presented in the following sequence:  
o Title page 
o Abstract 
o Text, including Introduction, Methods, Results, Discussion and Summary/Conclusions 
o Acknowledgments 
o Sources of Funding 
o Conflict(s)-of-Interest/Disclosure(s) 
o References 
o Figure Legends 
o Tables 
o Figures 
o Visual Abstract (ONLY for Basic Science Articles) 
o Online Supplement 
• Cite each reference in the text in numerical order and list in the References section. In text, 
reference numbers may be repeated but not omitted. Do not duplicate references either in text or 
in the reference list. 
• Cite each figure and table in the text in numerical order. 
• Upload one copy of any in-press article that is cited in the references, if applicable. 
• Upload one copy of any abstracts published or submitted for publication, if applicable. 
• Use SI units of measure in all manuscripts. For example, molar (M) should be changed to mol/L; 
mg/dL to mmol/L; and cm to mm. Units of measure previously reported as percentages (e.g., 
hematocrit) are expressed as a decimal fraction. Measurements currently not converted to SI 
units in biomedical applications are blood and oxygen pressures, enzyme activity, H+ 
concentration, temperature, and volume. The SI unit should be used in text, followed by the 
conventionally used measurement in parentheses. Conversions should be made by the author 
before the manuscript is submitted for peer review. 
• Provide $US dollar equivalents if you include other currency amounts in the manuscript. 
• Please provide sex-specific and/or racial/ethnic-specific data, when appropriate, in describing 
outcomes of epidemiologic analyses or clinical trials; or specifically state that no sex-based or 
racial/ethnic-based differences were present. See the Recommendations for the Conduct, 
Reporting, Editing, and Publication of Scholarly Work in Medical Journals for more details. 
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• Please review the correct usage of the terms “sex” and “gender.” “’Gender’ refers to a person’s 
self-representation...or how that person is responded to by social institutions on the basis of the 
person’s gender presentation. ‘Gender’ is rooted in biology and shaped by environment and 
experience;” “sex” describes a class of “living things as male or female according to their 
reproductive organs and functions assigned by chromosomal compliment” (AMA 10th ed. 2007: p 
395. Please use the terms appropriately. 
• December 2016:  Confidence intervals should be reported instead of P values for estimated 
parameters, such as odds ratios and relative risks; P values should be reported only for relevant 
analytic tests. Authors are encouraged to avoid the pitfalls associated with the misuse of P 
values as measures of significance. Please refer to "The ASA's Statement on p-Values: Context, 
Process, and Purpose." The American Statistician. 2016.70;2: 129-
133. http://dx.doi.org/10.1080/00031305.2016.1154108.  
• Authorship Responsibility and Copyright Transfer Agreement Forms (and Licensing Agreements 
for Original Contributions) are ONLINE ONLY. Forms will be required PRIOR to resubmission, or 
if the manuscript has only one version (e.g., a letter to the editor) after acceptance. Each author 
will be sent an email containing a link to the form at the appropriate time. 
• Consult the AMA Manual of Style: A Guide for Authors and Editors, 10th ed, Oxford: Oxford 
University Press; 2007, for style. 
• Consult current issues for additional guidance on format. 
Title Page 
• The first page of the manuscript should be the title page. This page must include: 
• Full title of the article, limited to 120 characters. 
• Authors’ names, highest academic degree earned by each, authors’ affiliations, name and 
complete address for correspondence, and address for reprints if different from address for 
correspondence. Please also include any study group or collaboration in the author list, i.e., “ . . 
.Last Author, on behalf of the Stroke Study Group” 
• Fax number, telephone number, and e-mail address for the corresponding author. 
• Cover title (total characters must not exceed 50, including spaces) to be typeset on the top of the 
journal page. 
• Total number of tables and figures, e.g., Tables 2; Figures 3. 
• 3 to 7 key words for use as indexing terms. Consider using terms found in the Medical Subject 
Headings (MeSH) database. 
• Subject Terms for use as search terms across Highwire Press online journals Article Collections 
database. Please select from the Journal Subject Terms List. 
• Specify the number of words in the whole document on your title page, e.g., Word Count: 4896. 
Word count should include all parts of the manuscript (i.e., title page, abstract, main body of text, 
acknowledgments, sources of funding, disclosures, references, figure legends, tables, and 
appendices intended for print publication). Over-length manuscripts will NOT be accepted for 
publication. See the Costs to Authors above. 
Abstract 
• Do not cite references in the abstract. 
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• Limit use of acronyms and abbreviations. 
• Be concise (300 words, maximum). 
• December 2015: For authors following the PRISMA guideline, please use the journal abstract 
headings detailed below. 
• The abstract should have the following headings:  
o Background and Purpose (description of rationale for study) 
o Methods (brief description of methods) 
o Results (presentation of significant results) 
o Conclusions (succinct statement of data interpretation) 
o When applicable, include a fifth heading: “Clinical Trial Registration” Please list the URL, as 
well as the Unique Identifier, for the publicly accessible website on which the trial is registered. 
If the trial is not registered, please indicate the reason in the heading.  
 Example 1: Clinical Trial Registration-URL: http://www.clinicaltrials.gov. Unique identifier: 
NCT00123456. 
 Example 2: Clinical Trial Registration-URL: http://www.controlled-trials.com. Unique 
identifier: ISRCTN70000879. 
 Example 3: Clinical Trial Registration-URL: http://www.chictr.org. Unique identifier: ChiCTR-
RCH-14004884. 
 Example 4: Clinical Trial Registration-This trial was not registered because enrollment 
began prior to July 1, 2005. 
Text 
• The following are typical main headings: Materials and Methods, Results, Discussion, and 
Summary. 
• Abbreviations must be defined at first mention in the text, tables, and figures. 
• Introduction: This section should briefly introduce the context of the results to be presented and 
should duplicate what is contained elsewhere in the manuscript 
Methods: 
• NEW September 6, 2017: Please ensure that your manuscript adheres to the AHA 
Journals' implementation of the Transparency and Openness Promotion (TOP) Guidelines 
(available online at http://www.ahajournals.org/content/TOP-guidelines). In most cases, 
this means adding a sentence to the Methods section. 
• For any apparatuses used in Methods, the complete names of manufacturers must be supplied. 
• For human subjects or patients, describe their characteristics. 
• For animals used in experiments, state the species, strain, number used, and other pertinent 
descriptive characteristics. 
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• When describing surgical procedures on animals, identify the preanesthetic and anesthetic 
agents used, and state the amount or concentration and the route and frequency of 
administration for each. The use of paralytic agents, such as curare or succinylcholine, is not an 
acceptable substitute for anesthetics. 
• For other invasive procedures on animals, report the analgesic or tranquilizing drugs used. If 
none were used, provide justification for such exclusion. 
• Manuscripts that describe studies on humans must include a statement indicating if ethics 
approval was obtained from the local institutional review board and if written informed consent 
was obtained from patients or if the board waived the need for patient consent. 
• Manuscripts involving animals must indicate that the study was approved by an institutional 
animal care and use committee. 
• Reports of studies on both animals and humans must indicate that the procedures followed were 
in accordance with institutional guidelines. 
• All drugs should be referred to by their generic names rather than trade names. The generic 
chemical identification of all investigational drugs must be provided. 
• A statistical subsection must be provided at the end of the Methods section describing the 
statistical methodology employed for the data presented in the manuscript. 
• The Methods section should provide essential information related to the conduct of the study 
presented in the manuscript. For methodology previously published by the authors, the prior 
publication should be referenced and a copy of the paper provided to the reviewers, if necessary. 
• The Methods section should only contain material that is absolutely necessary for 
comprehension of the results section. Additional (more detailed) methods can be provided as a 
data supplement. 
• Prevention of bias is important for experimental stroke research (see Macleod et al, 
Stroke.2009;40:e50-e52). For studies where the primary objective is the preclinical testing of 
therapies, the following checklist items must be adhered to and clearly documented in the 
manuscript:  
o Animals: Species, strains and sources must be defined. For genetically modified animals, 
wildtype controls including background and back-crossing must be defined. 
o Statistics and sample size: Specific statistical methods must be defined, including parametric 
versus nonparametric and multigroup analyses, and sample size powering based on expected 
variances and differences between groups. 
o Inclusions and exclusions: Specific criteria for inclusions and exclusions must be specified. For 
example, only animals where blood flow reductions fall below a certain threshold are included. 
Or only animals with a certain degree of neurological deficits are included. Once animals are 
randomized (see below), all excluded animals must be reported, including explicit presentation 
of mortality rates. 
o Randomization, allocation concealment and blinding: All animals must be randomized. 
Investigators responsible for surgical procedures or drug treatments must be blinded. End 
point assessments must be performed by investigators blinded to the groups for which each 
animal is assigned. 
• Any submitted meta-analyses should follow the PRISMA or MOOSE guidelines. The authors 
must clearly state in the Methods section which guideline was followed. Details on PRISMA can 
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be found here http://www.prisma-statement.org. Details on MOOSE can be found via the 
EQUATOR Network. 
Results: 
This section should succinctly report the results of experimental studies and clinical research or 
clinical series/observations. 
Confidence intervals should be reported instead of P values for estimated parameters, such as 
odds ratios and relative risks; P values should be reported only for relevant analytic tests. 
Authors are encouraged to avoid the pitfalls associated with the misuse of P values as measures 
of significance. Please refer to "The ASA's Statement on p-Values: Context, Process, and 
Purpose." The American Statistician. 2016.70;2: 129-
133. http://dx.doi.org/10.1080/00031305.2016.1154108.  
Discussion: 
This section should not reiterate the results but put the results in appropriate context regarding 
relevant literature and the importance of new observations contained in the manuscript. 
Summary/Conclusions: 
A brief paragraph summarizing the results and their importance may be included but is not 
required. 
Acknowledgments 
The acknowledgments section lists all substantive contributions of individuals. Authors should 
obtain written, signed permission from all individuals who are listed in the “Acknowledgments” 
section of the manuscript, because readers may infer their endorsement of data and conclusions. 
These permissions must be provided to the Editorial Office. Please see the Acknowledgment 
Permission Form. The corresponding author must mark the following statement on the ONLINE 
ONLY Copyright Transfer Agreement form or Licensing Agreement, certifying that (1) all persons 
who have made substantial contributions in the manuscript (e.g., data collection, analysis, or 
writing or editing assistance), but who do not fulfill authorship criteria, are named with their 
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Abstract 
Background and Purpose- Stroke is one of the leading causes of disability worldwide, with 
lower rates of recovery linked with patients’ participation in rehabilitation. The purpose of 
this study was to conduct a prospective examination of the relationship between night time 
sleep, and participation in rehabilitation in an acute hospital setting. The study also 
considered the temporal relationship between mood and participation in rehabilitation, as 
well as the possible interplay between sleep and mood.                                                                                                                         
Methods- Experience sampling methodology was integrated with actigraphy, across a range 
of between 3-15 days (mean-7.5, SD=4.4) in 20 participants (53% female, mean age= 74, 
SD= 11.8) who had experienced a recent stroke and were undergoing inpatient rehabilitation 
Daily measures of sleep, mood, pain and participation were recorded for each participant for 
the duration of the study.  Multilevel modelling was employed for data analysis.                                                                                                                            
Results- Results indicate that sleep efficiency was a predictor of participation in 
rehabilitation, however, this significance was not sustained in a more stringent model that 
accounted for other predictor variables. Experiences of low mood predicted lower levels of 
participation in activities of rehabilitation, while a small increase in pain experience 
predicted increased levels of participation. All findings are at a within-person level.                                                                                                   
Conclusions- For the first time we show that sleep efficiency is linked with participation in 
rehabilitation. We also show that there is a temporal relationship between experiences of 
mood and pain and participation in rehabilitation in a post-stroke population. Results 
indicate that sleep, mood and pain are linked with a person’s ability to participate in 
activities in rehabilitation. Interventions targeting these experiences may improve 
participation in rehabilitation and consequently may have an impact on a person’s recovery 
from stroke.     
Key words: ▪Stroke, ▪rehabilitation, ▪sleep, ▪mood, ▪actigraphy, ▪experience sampling 
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Introduction 
Stroke is the second leading cause of death worldwide 1 and has been described as 
the most debilitating of conditions 2; likely due to its wide-reaching impact across several 
life domains.  Stroke occurs suddenly and often without warning 3, affecting approximately 
2-3 individuals per 100 per year.  Despite recent advances in treatment, it remains the most 
common neurological cause of hospitalisation and disability in adulthood worldwide 4. 
Advances in the recognition and treatment of stroke have led to improved survival rates, 
with mortality rates falling by 35% 5.  Thus, there is an increased need for longer term and 
specialist care for stroke survivors and their families, as increasingly more people are living 
with the consequences of stroke and the resulting cognitive, physical, and emotional 
difficulties 6, 7. 
Stroke is associated with a range of sleep and mood related difficulties 8-10.  Poor 
sleep efficiency (SE), lower total sleep time (TST), and experiences of low mood and 
depression 11-13 are commonly reported difficulties following stroke. Over the past 20 years, 
research into the aetiology of stroke has suggested that optimising functional recovery is 
contingent upon engagement with an intense programme of rehabilitation 14.  Front line 
rehabilitation efforts focus on motor and cognitive re-learning of functional skills. This 
process of re-learning can be both demanding and challenging for participants and can be 
impacted by a number of factors for example cognitive function 15.  However, the potential 
impact of sleep and mood disturbances on participation in rehabilitation following stroke 
remains unclear.    
Existing research examining the relationship between stroke and sleep has found that 
various types of sleep disturbance, such as insomnia, sleep disordered breathing (SDB), and 
restless leg syndrome (RLS) are common in people who have experienced stroke, impacting 
as many as 50% of stroke survivors 16, 17. Furthermore, there is emerging evidence that 
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patients experience significant difficulties with sleep whilst in hospital 18, 19, possibly due to 
the effect of light and noise pollution on medical wards 20.  This is particularly relevant to 
the stroke population given that the length of inpatient stays for stroke rehabilitation range 
between 13-162 days 21, 22. Therefore, hospital settings may further impair both sleep quality 
and efficiency at a time when its importance is paramount.  It has been well documented that 
sleep disturbances have a negative impact on physical health recovery 16 and are strongly 
correlated with experiences of depression and anxiety in both post stroke and healthy 
populations 23, 24. Poor sleep is also correlated with poorer life satisfaction, as well as lower 
functional recovery following stroke 16, 25. One possible reason for this link is that sleep 
promotes neuroplasticity which is essential for the neural processes of memory and learning 
26, 27. These processes are fundamental to a person’s ability to learn and retain new skills 
acquired during rehabilitation activities. Evidence of this link can be found in literature 
which suggests that sleep promotion can facilitate recovery in a stroke population 24, 28.   
 In addition to difficulties with sleep, around one third of all stroke survivors 
experience difficulties with mood and approximately 10% receive a diagnosis of major 
depression with co-morbid anxiety 29. Mood difficulties can be further exacerbated and 
compounded by prolonged stays in hospital 30, 31.  Moreover, it is common for people to 
experience a range of other emotional and psychological difficulties such as anger, 
frustration, helplessness, low self-esteem, and apathy 32, 33.  The experience of emotional 
difficulties has been linked with reduced independence 34, lower quality of life, increased 
mortality and participation in rehabilitation 35, 36. Research in other health populations 37, 38 
has also indicated that mood has a significant impact on recovery and that functional 
improvements can be better achieved when both psychological and physical health needs are 
addressed 39, 40.   
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Although some research has been conducted into the possible impact of mood on a 
person’s participation with rehabilitation 41, this area remains relatively unexplored.   
There is a dynamic and reciprocal relationship between mood and sleep 42, 43.  Clear 
links have been found between the experiences of low mood and/or anxiety and sleep 
disturbances in general populations 44.  Furthermore, it has been suggested that individuals 
who have a lower average SE (a percentage of amount of time asleep compared with the 
time spend in bed) or sleep difficulties are often less able to cope with the emotional and 
psychological consequences of difficult situations. This in turn may lead to more 
experiences of anxiety and depression 45. Difficult experiences with mood and sleep can 
have a negative impact on wellbeing, however the bi-directional relationship between mood 
and sleep is yet to be examined in this population.  
With the main aim of stroke rehabilitation activities being to support functional 
recovery and a return to a meaningful life for the survivor 46, it is unsurprising that improved 
participation in rehabilitation activities can have a positive impact on overall recovery rates 
47. The link between recovery and participation warrants further investigation in the stroke 
population; however, research in cancer populations has demonstrated that both mood and 
sleep deficits can have a negative impact on a person’s ability to engage in their 
rehabilitation activities 48. Although sleep and mood have been implicated in rehabilitation 
literature as factors which influence participation, pain has also been noted as an important 
factor in a person’s ability to participate 49.  Empirical findings suggest that experiences of 
pain as well as a fear of inducing pain during rehabilitation often impede a patient’s ability 
and/or motivation to engage 50. Pain is an important variable to measure, as research posits 
that it has impact on both mood and social engagement within a stroke population 51.    
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The research outlined above indicates that sleep and mood difficulties following 
stroke are common and linked with poorer outcomes.  Furthermore, current evidence 
suggests that participation in rehabilitation activities is linked with improved levels of 
functional recovery.  There is some evidence to suggest that experiences of poor sleep, low 
mood and pain can have a negative impact on a person’s ability to engage with rehabilitation 
52, 53, however, the temporal mechanisms of this association remain unclear.  Understanding 
how sleep and mood may impact a person’s ability to engage with rehabilitation is 
imperative in terms of supporting patients to access rehabilitation to the best of their ability.   
Increasing participation in rehabilitation may result in improved rates of recovery as well as 
reducing the length of stay in a rehabilitation unit, reducing the global economic burden of 
stroke.  
The purpose of this study was to evaluate the reciprocal and dynamic relationship 
between sleep and mood on participation in rehabilitation over time, while controlling for 
the possible impact of pain using an experience sampling approach (ES). The study aimed to 
address the following questions: 
1. Does sleep predict participation in rehabilitation?  
2. Does sleep predict mood, and in turn does mood predict sleep? 
3. Does mood predict participation in rehabilitation across time?  
4. Does sleep and/or mood predict participation in rehabilitation after 
controlling for pain. 
It was hypothesised that; (i) improved rates of Sleep (SE and TST) would predict 
increased participation in rehabilitation; (ii) that sleep and mood would demonstrate a 
reciprocal relationship; (iii) low mood would be negatively related to participation in 
rehabilitation; (iv) that after controlling for the possible confounding impact of pain, that 
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improved sleep (SE and TST) and mood would be significantly positively associated with 
participation in rehabilitation.  
Method 
 
 An experience sampling (ES) method 54 was employed to evaluate the relationship 
between sleep, mood, pain and participation in rehabilitation. By collecting daily measures 
of the variables, the ‘real time’ relationship between them was determined.  This study was 
reviewed and approved by the National Health Service (NHS) Research and Ethics 
Committee (REC ref: 17/SC/0421), and by local research and development offices. 
Participants 
 
A convenience sample of participants was recruited from one local NHS trust in the 
Northwest of England. All participants had experienced a stroke (ischaemic or 
haemorrhagic) as established by medical clinical assessment and either a Computerized 
Tomography (CT) scan or Magnetic Resonance Imaging (MRI) scan. Participants had been 
admitted onto an acute stroke ward and resided there for a minimum of 48 hours prior to 
being invited to participate in this study.  All participants were expected to remain as an 
inpatient for the duration of data collection (between 3-15 days). Participants were required 
to have a command of the English language sufficient to complete assessments, be fully 
conscious (or able to awaken to full consciousness during evaluations) and provide informed 
consent for participation.  Participants were required to be orientated to time (year) and 
place and were all over the age of 18.   
Participants were excluded from the study if they: (a) had a current or previous 
diagnosis of sleep apnoea, (b) had a significant cognitive impairment which impaired their 
ability to provide informed consent, or (c) had significant impairments to mobility, which 
inhibited the use of an actigraph.  




All participants completed measures of mood and pain (baseline and daily) as well as 
an assessment of their current cognitive function at baseline. As this study included 
participants with aphasia, three of the measures detailed below were selected due to their 
suitability for use with potential participants who were experiencing significant 
communication difficulties.  
 Hospital Anxiety and Depression Scale (HADS).  The HADS is a validated, 
widely-used, self-report scale, in which participants are asked to rate their agreement with 
seven anxiety and seven depressive items over the previous week on a four-point scale (0 to 
3) to give a maximum score of 42 55. The HADS excludes most somatic symptoms, 
therefore avoiding potential confounders in a hospital-based, physically unwell population. 
The scale has been normed and validated for use within the stroke population 56 and 
demonstrates acceptable internal consistency (Cronbach’s α = 0.79) 57.  
Depression Intensity Scale Circles (DISCS). The DISCS is a visual measure of low 
mood and was used to determine current levels of depression with participants who were 
experiencing aphasia.  The DISCS was developed within the context of a brain injury 
population and has been validated within an aphasia population demonstrating a strong 
reliability (Cronbach’s α = 0.83) compared with the Beck Depression Inventory (BDI) 58.  
Behavioural Outcome of Anxiety Scale (BOA) - carer. This is a ten-item measure of 
anxiety where carers of the participants were asked to rate the frequency of participants 
experiences of anxiety on a four-point scale between 0-3, with maximum possible score of 
30 59. The BOA-carer has been validated within the stroke population and has demonstrated 
strong reliability (Cronbach’s α = 0.81) in identifying experiences of anxiety, 60.   
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Numerical pain rating scale supplemented with the Faces pain scale - NPRS-FPS. 
The NPRS-FPS is a visual measure of pain 61 which consists of a 100mm line with 0 (no 
pain) and 10 (worst possible pain) at the other, the numbers were supplemented with faces 
indicating a neutral face at 0 and a tearful face at 10. This measure has been validated within 
a stroke population, with good internal reliability (intra-class correlation coefficient (ICC) = 
0.82). This measure was used with both participants with and without aphasia.  
Montreal Cognitive Assessment (MoCA). The MoCA 62 is a 30-point global 
cognitive screening tool used to assess stroke-relevant domains. It has been shown to have 
good sensitivity in detecting post-stroke cognitive impairment as well as global impairment 
and has strong internal consistency (Cronbach α = 0.83) 63. Experiences of cognitive 
impairment has been linked with limited participation with rehabilitation 64 
Oxford Cognitive Scale (OCS). The OCS is a short cognitive screen which provides 
a profile of the participants’ cognitive abilities. This scale has been validated within a 
population of people experiencing aphasia 65 and has demonstrated fair internal reliability 
(ICC= .55).  This measure was used to assess cognition for participants who have been 
identified as aphasic. 
 Visual Analogue Mood Scale -Revised (VAMS-R). The VAMS-R 66 was 
administered to participants once per day for the length of time they were active in the 
study.  The VAMS has demonstrated validity and reliability in a stroke population, 
(Cronbach’s α = 0.71). It measures eight specific mood states (afraid, confused, sad, angry, 
energetic, tired, happy and tense).  Participants in this study were asked only to rate 
themselves using the ‘sad’ mood construct, due to this study investigating the relationship 
between the experience of low mood on participation in rehabilitation 67.  The measure is a 
simple cartoon face with verbal descriptors of “sad” at one end of the 10-centimetre line and 
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“neutral” at the other.  Results range from 0-100, with higher scores indicating increased 
experience of sadness.   This visual measure was chosen as it places minimal cognitive and 
linguistic demands on the respondent and is appropriate for neurologically impaired 
individuals 68. This measure was used with both aphasic and non-aphasic participants.  
Sleep. Objective measurement of sleep-wake patterns was obtained via wrist 
actigraphy (GENEActive, Activeinsights, Cambs, UK).   Actigraphy provides a recording of 
continuous motor activity and has been used before within the stroke population 69. All 
participants were instructed to wear the actigraph on their most mobile wrist for a maximum 
of 15 days or until discharge. The raw actigraph data was analysed using GGIR 70 which is 
an open source R package, whose algorithms are designed to characterise sleep and have 
shown high sensitivity and specificity when characterising sleep patterns.  GGIR algorithms 
use estimated arm angles which are averaged every 5 second epoch and used to assess the 
change in arm angle between sequential epochs. Periods of time during which there is no 
change in the arm angle >5◦ over at least five minutes are classified as bouts of sustained 
inactivity, or potential sleep periods. Total sleep time (TST) and sleep efficiency (SE) were 
the constructs considered for this study as they have been identified by previous research to 
be the most impaired functions following stroke 17.  
The Pittsburgh Rehabilitation Participation Scale (PRPS). The PRPS has been 
validated and normed against a stroke population and has been shown to correlate with 
functional outcomes for patients experiencing neurological and orthopaedic conditions 
(ICC= 0.91) 71.  The PRPS is a clinician-rated, 6-point Likert-type item measuring patient 
participation in inpatient rehabilitation sessions.  The PRPS was completed by the relevant 
clinician after each structured session of rehabilitation therapy that the participant was 
offered, including physiotherapy, speech and language therapy and occupational therapy.  
SLEEP, MOOD AND PARTICIPATION IN A STROKE SAMPLE.  2—11 
 
Where participants were involved in more than one session of rehabilitation per day, the 
mean value of all the scores was used as the daily score. 
Procedure 
 
Participants who met the inclusion criteria and gave their informed consent to take 
part in the study were invited to complete the baseline measures of mood and pain, which 
were conducted by the lead author (LR).  If not already available from routine clinical 
records, a cognitive screen was conducted by (LR). All verbal measures were read to the 
participants, who were provided with written response choices in large-point font.  
Following baseline measures, the participants were provided with an actigraph and were 
advised that they did not need to take it off for the duration of the study.  Each actigraph was 
set to begin recording at midnight on the night of enrolment into the study.  The daily 
measures of mood, pain and participation commenced the following day and were 
conducted by members of the research team. Once the participants had completed the study 
(at a maximum of 15 days or upon discharge from the acute ward), they were debriefed and 
the actigraph was collected. The daily measures of participation were then retrieved from the 
clinical team. A copy of all the measures used in the study can be found in section four of 
this thesis.  
Data Analysis 
 
All analyses were conducted using R program 72. Descriptive/exploratory analyses 
were computed to evaluate the characteristics of baseline and experience sampling (ES) 
data.  All participant level and day level data were assessed via graphical inspection. To 
answer the main research questions, a series of hierarchical linear models or multi-level 
models (MLM) were built.  This analysis strategy was able to take into account the nested 
nature of the data.  An initial unconditional means model was used to evaluate levels of 
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between and within- person variance on participation in rehabilitation and other time variant 
predictors such as sleep, mood and pain. As a complement to time variant predictors (“state 
variables”), new “trait average” time invariant predictors were generated and included in 
final models.  Linear growth models using Lag 1 auto-regression with random intercepts and 
slopes were used to answer the five main questions. This type of model is useful to remove 
time-dependencies in the data and demonstrated a better fit than those that did not take into 
account this dependency.  Considering the exploratory nature of this study we did not 
conduct corrections for multiple tests.  
Results 
 
Demographics and clinical characteristics 
 
Twenty-five participants were approached to take part in this study. Four participants 
were excluded due to difficulties with orientation to time and place and one participant due 
to a pre-existing clinical diagnosis of sleep apnoea. Of the final 20 participants recruited, 
one withdrew following baseline data collection, resulting in a final sample of 19 with ES 
data.  
The average length of participation in the study was 7.5 days (SD=4.4). Participant 
age ranged from 56-94 with a mean age of 74 (SD=11.8).  The ratio of male to female was 
relatively equal (53% females). Seventeen participants had an ischemic stroke and left sided 
deficit was the most common experience (n=12). In terms of baseline evaluations, mean 
scores for depression and anxiety were 7.5 (SD=5.3) and 8.9 (SD=5.1) respectively.  As the 
clinical cut off score for the HADS is >8, it could be argued that experiences of anxiety and 
depression for this sample would meet the clinical threshold for mood difficulties within the 
moderate range 73.  The mean baseline pain score for the sample was 2.3 (SD=2.8), therefore 
given that the maximum possible score is 10, this is suggestive of lower levels of pain across 
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the sample 61. Finally, cognitive functioning scores indicate that on average participates in 
this sample were experiencing mild cognitive impairment (Mean= 18.9, SD= 6.9).  (Table 
1).  
Insert Table 1 
Compliance with the actigraph was good. The mean number of nights of data 
collected was 7.5 (SD = 4.4), representing a total of 202 measures of sleep across the 
sample. Daily measures of mood and pain had a 98% collection rate across the sample, 
which is a result of four missing data points. This equated to one missing day across four 
participants.  Participation in rehabilitation scores were recorded 170 times across the data 
set, out of a possible 172 sessions of rehabilitation provided. This represented a 99% 
completion rate. Measures of sleep, mood and pain were collected seven days per week, 
whereas measures of participation in rehabilitation were collected Monday-Friday as clinical 
rehabilitation activities were not conducted at the weekends.  
Descriptive details of the ES data are also shown in table 1. Mean SE was 63% (SD= 
18%), and TST was 396 minutes in a 24-hour period (SD= 136 minutes). In terms of mood, 
the mean was 25.5 (SD= 33), and the mean of pain was 2.4 (SD= 2.4). Finally, the mean of 
our main outcome; participation in rehabilitation, was 4.3 (SD = 1.2) out of a possible score 
of 6, reflecting a high average level of participation across the sample.  Figure’s 1 to 4 show 
the state (time variant) and trait (time invariant) predictor variables (sleep, mood, pain). 
These plots demonstrate the variability across the sample for all predictor variables, 
specifically how they vary within and between persons.  There was significant variability 
between and within participant’s score on daily measures. For example, the between ICC 
(between person variance) for participation was 34% and the within ICC (within-person 
variance) was 66%. 
SLEEP, MOOD AND PARTICIPATION IN A STROKE SAMPLE.  2—14 
 
Insert Figure 1 to 4 
 
Relationship Between, Sleep, and Mood on Participation in Rehabilitation Following 
Stroke.  
 
To explore the first research question ‘does sleep predict participation in 
rehabilitation?’, two MLM’s were conducted which explored the relationship between 
participation in rehabilitation and both the state and trait versions of the sleep variables, SE 
and TST. Table 2 shows that SE variables are predictors of participation in rehabilitation. SE 
state (a time variant predictor) showed a significant association with participation 
rehabilitation after controlling for SE trait-average (a time invariant predictor) (b=1.58, 
p=.04). This result indicates the expected difference in participation on a day with one unit 
increase in SE for a prototypical participant. In other words, on days with higher state sleep 
efficiency the prototypical participant had higher levels of participation across the following 
day. Comparatively, neither state nor trait total sleep time was associated with the level of 
participation in rehabilitation (p.>.05) (Table 3).    
Insert Tables 2 and 3 
 To explore the second research question ‘does sleep predict mood, and in turn does 
mood predict sleep?’, two MLM’s were performed. Analysis revealed that there was no 
significant reciprocal relationship between either of the sleep constructs and mood. Neither 
sleep efficiency nor total sleep time (state or trait-average) were associated with mood 
(p.>.05) (Tables 4 and 5).  Furthermore, daily mood (state or trait-average) was not a 
significant prospective predictor of either sleep efficiency or total sleep time (p. >.05) 
(Tables 6 and 7).    
Insert Tables 4 to 7 
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A further MLM was completed to determine the effect of mood on participation in 
rehabilitation (question three). In line with our hypothesis, the results indicated that mood 
was a significant predictor of participation in rehabilitation. Table 8 shows that the mood 
variable (trait average) demonstrated a significant negative association with participation in 
rehabilitation (b=-.02, p=.02) after controlling for mood state.  Given that a higher score in 
the mood variable indicates poorer mood, average lower mood was significantly associated 
with lower levels of participation.    
Finally, to explore the fourth research question ‘does sleep and/or mood predict 
participation in rehabilitation after controlling for pain?’, a more stringent MLM, with all 
predictor variables together was conducted.  Daily mood (state) scores (b= -.01 p=.02) and 
daily pain (state) (b=.12, p=.01) both significantly predicted participation levels. (Table 9).  
These results indicated that low mood was negatively associated with participation in 
rehabilitation and an increase in pain was positively associated with participation in 
rehabilitation at a within subject level.  Therefore, if a participant was feeling lower in mood 
today they would have lower levels of participation in rehabilitation tomorrow. Moreover, if 
a participant had a higher level of pain today, they would have increased levels of 
participation tomorrow.  
Insert Table 9 
Discussion 
 
 This is one of the first studies to consider the temporal effects of sleep and mood on 
participation in rehabilitation following stroke in an acute clinical setting. Understanding 
these effects could allow for the development of guidelines to support better participation in 
activities of rehabilitation, which may promote improved rates of recovery. The integration 
of actigraphy and ES enabled the longitudinal assessment of sleep-wake patterns, as well as 
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the assessment of mood, pain and participation in rehabilitation across various days and 
nights.  Findings from this study indicate that sleep efficiency, mood and pain predict levels 
of participation and rehabilitation within a sample of stroke participants.  
Average sleep efficiency (SE) for the stroke survivors in this sample was 62.7%, 
which is in line with extant literature 17.  It is widely accepted that SE is an important factor 
for both mental and physical health 74, with the recommended rate of SE for general 
populations being more than 80% 75. Analysis revealed that SE had a significant relationship 
with participation, which is in line with the first hypothesis.  However, this predictive ability 
did not remain significant when a more stringent model, which included all predictor 
variables was conducted.  SE does not account for as much of the variance in participation 
in rehabilitation scores as other variables. However, it appears that it may still have a role in 
participation in rehabilitation as increases in scores of participation can, in some part, be 
explained by the role of SE, as demonstrated by the first model.   
Previous literature has found that a reduction in TST has a negative impact on a 
person’s overall functional recovery from stroke 76. However, the current study did not find 
that TST was a significant predictor of participation in rehabilitation. One possible 
explanation for this is that the participants included in this study were achieving a good 
amount of sleep when compared with previous literature. Participants were achieving on 
average 76 minutes more sleep per night, when compared with other stroke populations 17.  
High TST could be accounted for by the nature of the sample.  Participants on average had 
experienced their stroke 15.5 days prior to commencing the study and they were all in the 
early stages of recovery and the body’s natural sleep requirement may have been higher than 
for patients who are further along their recovery journey. This is in line with research by 
Sommerauer and colleagues (2013) 77 who suggest that increased need for sleep following 
brain injury may be due to the bodies recovery mechanisms. This increased sleep need is 
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also supported by literature on the role of sleep in an acute hospital setting 78.  However, 
increased TST may extend beyond its own helpfulness. A recent study investigated the 
impact of increased TST in a stroke population and found that patients with higher TST (>8 
hours) were at greater risk of experiencing a further stroke 79. Ezeugwu et al, (2017) 79 posit 
that this increased risk of further stroke may be due to decreased physical activity which is 
highly correlated with increased TST.    
When interpreting the findings from this study it is useful to consider the mechanism 
of poor sleep following stroke that has been suggested by Baglioni and colleagues (2016) 17. 
They propose that sleep difficulties post-stroke are as a result of the cyclical relationship 
between poor sleep in the initial stage of stroke recovery and decreased psychological mood 
and motivation. Experiences of poor sleep leads to a reduction in motivation which impacts 
on a person’s desire and ability to engage in rehabilitation. As such, people may experience 
a further decrease in mood and sleep. It may be that had this study continued to monitor the 
participation, sleep and mood of participants following their discharge from hospital, that it 
would have identified this pattern.  This potential relationship is worthy of further 
investigation in future research.  
In line with our third hypothesis, low mood had a significant negative impact on 
participation. This supports previous findings which have identified that mood difficulties 
are prevalent in the post-stroke population and may impact on a person’s ability to 
participate in their activities of rehabilitation 80.  These findings have important clinical 
implications, given that participation in rehabilitation activities results in improved rates of 
recovery.  This study represents further evidence to support the development of both 
assessment and treatment options for mood following stroke.   
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Research into the reciprocal relationship between mood and sleep has been well 
documented in both general and mental health populations 81-83. Specifically, sleep 
disturbances have been linked with experiences of both low mood and anxiety in the stroke 
population 84, as well as low mood being linked with experiences of sleep disruption in both 
adult 85 and older adult populations 86.  The third research question hoped to explore this 
relationship further, by investigating the possible predictive ability of each variable on one 
another.  Findings from this study did not demonstrate a predictive relationship between 
sleep and mood.  It is possible that there are a number of reasons for this, such as sample 
size, and the possible confounding impact of pain.  These findings will be discussed below.  
The final MLM in this study examined the predictive impact of all variables (sleep, 
mood and pain) in terms of their possible relationship with participation.  It was found that 
when all variables were included in the model and baseline mood scores were controlled for 
that daily (state – time variant) mood and pain remained significant predictors of 
participation in rehabilitation. This finding that daily fluctuations in mood and pain can 
predict participation in rehabilitation, may mean that there is clinical value in taking into 
account this day-level interaction. This would allow clinicians to respond to patients’ needs 
as and when they present rather than engaging with experiences of low mood and pain as 
chronic conditions, that require a diagnostically driven treatment plan.   
A further finding of this study is that an increase in pain demonstrates a positive 
impact on participation in rehabilitation. This finding does not converge with wider health 
rehabilitation research, which posits that pain is an inhibitory factor for participation in 
rehabilitation 87.  Indeed, the hypothesis for looking at the relationship between pain and 
participation in this study was to control for its probable negative relationship.  One possible 
reason for this finding may be the level of pain experienced by participants in this sample 
was relatively low (mean = 2.4, SD=2.4). Meaning that a 1-unit increase in pain would 
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range between 3.4-5.8, (on a pain scale of 0-10 where 0 is no pain and 10 is the worst 
possible pain), suggesting that pain may still have been at a manageable level for the 
participants.   
Clinical and Research Implications 
 
Sleep. This study represents a significant addition to research considering sleep in an 
acute hospital setting. In line with previous literature, this study investigated sleep across 
two separate constructs in order to facilitate a more nuanced understanding of the impact of 
sleep on participation in rehabilitation following stroke. Measuring ‘sleep’ as one variable 
does not offer a meaningful understanding of an individual’s sleep-wake pattern. This is 
demonstrated by measurements of SE and TST being different in terms of their ability to 
predict participation in rehabilitation.   
The low SE across the sample reflects that a patient’s experience of sleep in an acute 
stroke rehabilitation setting is challenging and signifies an area for improvement. Research 
has demonstrated that frequent and prolonged disturbances in sleep can result in protracted 
and chronic difficulties with ongoing sleep disturbances post-discharge from hospital 88.  
Following release from hospital, patients may continue to experience disruption in sleep 
with significant deficits in SE as they attempt to re-establish a functional sleep schedule 89. 
Given that patients who experience low SE routinely report higher levels of psychological 
and physical difficulty 88, as well as lower overall quality of life 79, 90, addressing hospital 
sleep environments should be a priority for care providers.  Emerging evidence suggests that 
hospital settings may be able to improve the sleep environments for patients by considering 
the impact of light 91 and noise pollution 20, 92 during night time hours, as well as finding less 
invasive methods of continued physical health observation throughout the night.  Dubose 
and Colleagues (2016) 93, posit that small practical changes, such as providing patients with 
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ear plugs and eye masks, may improve sleep quality. However, in order to make significant 
and sustained improvements for patient sleep, the sound and light environments need to be 
addressed at a wider level. Further research is required in this area so as to ensure that all 
potential improvements to sleep quality can be made.  
Robinson et al (2005) posit that the body’s healing processes are at their peak during 
sleep; an important finding when considering the possible clinical impact of this study.  
However, given that TST has been associated with an increased risk of stroke and this study 
did not demonstrate any significant relationship with participation in rehabilitation, previous 
literature espousing the protective or recovery related properties of increased TST should be 
interpreted with caution.  It may be beneficial for overall patient functional recovery for 
TST to be monitored within the acute recovery setting.  In the event of a patient 
oversleeping (TST >8hrs), increased physical and social activity should be encouraged so as 
to mediate the impact of any associated functional loss. 
 Mood. Findings from this study are in line with previous literature that suggests that 
mood can have a significant impact on a person’s ability to engage with activities of 
rehabilitation following illness or injury 94-96.  Feelings of sadness or worry are very 
understandable experiences for patients recovering from stroke, given the potential and often 
inevitable life altering consequences of stroke.  Although these feelings are common in a 
post-stroke population, the underlying causes for this emotional distress are yet to be 
explored. In order to successfully address patient’s experiences of emotional distress, 
clinicians need to know more about the sources of these difficulties. One possible suggestion 
would be that during screening, clinicians could use measures that assess the person’s actual 
experience of distress.  One such tool could be the Distress Thermometer 97 and the 
accompanying problem checklist, which asks patients to rate their current level of distress 
and identify which life domains this distress is generated from.  This tool has been 
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successfully used within cancer services and participants have found it both acceptable and 
beneficial in terms of facilitating their access to appropriate care 98, 99. Clinical psychologists 
working in stroke rehabilitation settings are well placed to support staff and patients to 
understand more about the genesis of any distress and to use this knowledge to inform any 
subsequent interventions.   
In acute medical settings, it is possible that expressions of emotional distress are 
viewed by staff teams as clinical experiences that require treatment or intervention. 
However, often these experiences are normal emotional responses to distressing life events, 
such as a stroke.  It is important for clinical psychologists to work collaboratively with staff 
teams, supporting them to engage with patients about their experiences of distress and to be 
alongside the patient, rather than attempting to alleviate a normal human reaction to a 
traumatic life event.  
Pain. Our findings suggest that a small increase in pain is a predictor of increased 
participation in rehabilitation. This finding was significant even when the impact of mood 
had been controlled for, suggesting that the predictive value of pain in participation in 
rehabilitation is independent of its relationship with mood. When we consider this impact of 
lower levels of pain on participation in rehabilitation, it may be useful to draw on the 
theoretical concept of pain being a motivator for action 100. Consequently, participants in 
this sample who were experiencing lower level average pain, may have found that a small 
increase in their pain experience acted as a driver for increased participation in 
rehabilitation. This represents a novel finding and future research is required to understand 
more about this relationship between pain and participation in rehabilitation. 
Methodological Strengths and Limitations 
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Strengths of the study include a well characterised sample, with multiple measures of 
sleep, mood, pain, and participation across the sample. In contrast to experimental studies, 
the current study was an observational study which utilised ES methods.  ES is concerned 
with understanding the association between different variables across time within an 
individual, rather than a scientific association between variables across groups of people. 
This is a novel approach, given that current research in this area is dominated by cross-
sectional design. Moreover, this study’s unique ability to consider both the state and trait 
versions of predictor variables means that both within and between group associations were 
able to be tested.  Therefore, it may be possible to say that the current study sought to 
ask/answer questions that were most relevant to those of a clinician, for whom it would be 
important to know whether a person’s participation in rehabilitation post-stroke was 
impacted by their experiences of mood, sleep, or pain. Although the associations detected do 
not imply causation between variables, the model’s ability to take into account the potential 
lagged nature of the data helped to establish a temporal precedence between key variables 
within the acute clinical setting.  
The use of actigraphy in this study provided an indirect estimate of sleep, based on 
physical activity data.  Although it does not provide information on participants sleep 
architecture, like polysomnography, it remains a cost effective, non-invasive method of 
collecting information about a person’s sleep within the environment of interest. 
There are some limitations in the study that are inherent in its design. Several 
supporters of experience sampling studies have cautioned that between-persons and within-
person associations can differ in both magnitude and direction 101. This may in part explain 
this study’s finding that there are differences in the predictive ability of the state and trait 
versions of the variables. 
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 It has been argued that the process of ES may in fact interfere with the process being 
observed. This interference has been labelled ‘reactivity’ and refers to the process of 
repetitive measurement having an impact on the concept being measured. For example, 
asking a participant about their mood everyday may have the effect of influencing their 
mood without the addition of other factors 102, 103.  This issue of reactivity was minimised in 
this sample as participants had no retrospective access to their data, which has been shown 
to mitigate the reactivity response 104.  
  Another possible limitation of this study is that there is no clear guidance on power 
calculations for multilevel data 105, therefore it is difficult to evaluate the current approach, 
and as such it was difficult to estimate a recruitment threshold during study design.  Future 
studies should aim to recruit a larger sample and perhaps consider the exploration of 
variations in the sleep disturbance of patients accessing rehabilitation in hospital, compared 
with those in a community setting.  
 The decision to measure sleep using actigraphy alone precluded the measurement of 
subjective estimations of sleep. However, subjective measures of sleep are susceptible to 
reporting biases 106 and may have increased the cognitive load of participation on 
individuals who were already experiencing both physical and emotional stress. A further 
important factor to consider with the use of actigraphy is that it has a tendency to 
overestimate sleep and under report wakefulness 102, which has possible implications for this 
study sample due to the low activity levels of some of the participants. However, attempts 
were made to mitigate this complication by using the GGIR algorithm of arm angle 
discussed above. This could be another possible reason for the higher levels of TST in this 
sample.  Furthermore, the sample was opportunistic with the potential bias for the 
overrepresentation of participants who were experiencing poor sleep.  
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 Finally, in terms of generalisability of the findings, it should be noted that the 
majority of participants in this study were aged 65+ and were Caucasian in ethnic origin. 
Furthermore, the research was conducted on an acute stroke recovery ward based within the 
NHS.  While this sample is fairly representative of the wider stroke population in the UK in 
terms of age, gender and type of stroke, it should be emphasised that there was no ethnic 
diversity in the sample, meaning that results should be interpreted with caution in a more 
ethnically diverse setting.  There is a possibility that sleep and mood may demonstrate a 
different relationship to participation in rehabilitation between participants who have 
different types of stroke, cognitive profiles, or functional ability. Future research that 
compares the relationship of mood and sleep on participation with clearly defined 
participant characteristic controls would be required to answer this question.  
Conclusion 
 
 This study is novel in its investigation of the relationship between sleep, mood and 
pain on participation in rehabilitation in an acute stroke setting. Findings support previous 
literature on the relationship between mood and participation in rehabilitation post-stroke, as 
well as offering novel findings regarding the possible motivating factor of pain. SE in the 
sample was much lower than recommended levels and increased SE had a positive 
association with participation scores. The low SE of the participants and its relationship with 
participation in rehabilitation in this study suggests that sleep difficulties remain a factor for 
consideration in a hospital setting.  Further research is required to conceptualise our 
understanding of the impact of SE as well as the interplay between mood and pain and their 
relationship with participation in rehabilitation.  
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Table 1 
Participants Demographics and Scores on Baseline Measures (n=19) 
 
Demographics/ variables  Mean (SD)  Range 
Demographics     
  Age (years)  74 (11.8)  56-94 
  Gender Female, n (%)  10 (52.6%)   
  Experience Aphasia n (%)  4 (21%)   
     
Time since stroke (days)  15.5 (14.4)  2-46 
Type of stroke, n (%) 
  Ischemic 







Side of deficit, n (%) 
  Left 
  Right 









Number of medications being taken 
that might impact sleep/mood 
 1.2 (1.2)  0-4 
Baseline Variables     
  Depression (HADS)  7.5 (5.3)  0-18 
  Anxiety (HADS)  8.4 (5.1)  0-16 
  Pain (FPRS)  2.3 (2.8)  0-8 
  Cognitive assessment (MOCA)  18.9 (6.9)  11-29 
Experience Sampling 
   Sleep Efficiency (%) 
   Total Sleep Time (minutes) 
    Mood* 
    Pain* 
















Note: * Higher score represents lower mood, increased pain, and improved participation.  
 
SLEEP, MOOD AND PARTICIPATION IN A STROKE SAMPLE.  2—38 
 
Table 2.  
Effect of Sleep Efficiency (State and Trait) on Participation in Rehabilitation.  
 





Variable b Se P Lower Upper 
Intercept 3.78 0.98 0.00 1.85 5.72 
Time -0.01 0.03 0.77 -0.07 0.05 
Sleep Efficiency (state) 1.58 0.76 0.04 0.08 3.08 
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Table 3.  
 
Effect of Total Sleep Time (State and Trait) on Participation in Rehabilitation.  
 





Variable b Se P Lower Upper 
Intercept 4.71 0.80 0.00 3.12 6.29 
Time 0.01 0.03 0.83 -0.06 0.07 
Total Sleep Time (state) 0.08 0.06 0.12 -0.04 0.21 
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Table 4.  







Variable b se P Lower Upper 
Intercept 23.67 27.19 0.39 -29.97 77.32 
Time -0.40 0.59 0.50 -1.57 0.77 
Sleep Efficiency (state) -19.10 13.25 0.15 -45.26 7.05 
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Table 5.  
 







Variable b se P Lower Upper 
Intercept 5.48 21.40 0.80 -36.78 47.76 
Time -0.70 0.75 0.35 -2.15 0.77 
Total Sleep Time (state) -1.53 1.15 0.18 -3.80 0.74 
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Table 6.  
 
Effect of Mood (State and Trait) on Sleep Efficiency. 
 





Variable b se P Lower Upper 
Intercept 0.63 0.05 0.00 0.54 0.72 
Time 0.00 0.00 0.48 -0.00 0.01 
Mood (state) -0.00 0.00 0.24 -0.00 0.00 




















SLEEP, MOOD AND PARTICIPATION IN A STROKE SAMPLE.  2—43 
 
Table 7.  
 
Effect of Mood (State and Trait) on Total Sleep Time. 
 





Variable b se P Lower Upper 
Intercept 6.17 0.64 0.00 4.91 7.43 
Time -0.05 0.05 0.26 -0.14 0.04 
Mood (state) -0.01 0.01 0.07 -0.02 0.00 
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Table 8.  
 







Variable b se P Lower Upper 
Intercept 5.05 0.31 0.00 4.46 5.64 
Time -0.01 0.28 0.58 -0.07 0.04 
Mood (state) 0.00 0.01 0.95 -0.01 0.01 




















A Stringent model of all Predictor Variables and their effect on Participation in 
Rehabilitation.  
 





Variable b se P Lower Upper 
Intercept 3.90 0.61 0.00 2.96 5.01 
Time -0.23 0.03 0.43 -0.08 0.03 
Sleep Efficiency (state) 0.83 0.60 0.17 -0.35 2.01 
Mood (state) -0.01 0.00 0.02 -0.01 -0.00 
Pain (state) 0.12 0.05 0.01 0.03 0.22 
Baseline Anxiety 0.00 0.05 0.95 -0.11 0.08 
Baseline Depression -0.01 0.04 0.79 -0.10 0.11 
 




Figure 1. State and trait versions of the data for sleep efficiency: This figure illustrates the level of within and between person variability at both a time 
variant and time invariant level.   





Figure 2. State and trait versions of the data for total sleep time: This figure illustrates the level of within and between person variability at both a time 
variant and time invariant level.   




Figures 1-4: State and Trait versions of predictor variables.  
Figure 3. State and trait versions of the data for mood: This figure illustrates the level of within and between person variability at both a time variant and 
time invariant level.   
 




Figure 4: State and trait versions of the data for pain: This figure illustrates the level of within and between person variability at both a time variant and 
time invariant level.   
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Introduction 
The aim of the critical appraisal is to evaluate both the systematic literature review and 
the research paper by discussing the salient issues that arose during the completion of this 
thesis. In the course of reflecting on the systematic review and research paper processes, a 
number of topics warranted further consideration, however, it was not possible to discuss these 
in the respective papers. Thus, this critical appraisal will be utilised as a forum for the in-depth 
consideration of the following topics; the measurement and classification of 
emotional/psychological distress experienced following stroke; sleep in an acute hospital setting 
and the opportunities for change; the role of clinical psychology in an acute hospital setting; and 
conducting an experience sampling study.  
 This research is particularly timely given the recent publication of the National Clinical 
Guideline for Stroke 1. Research has found that the incidence of stroke and its subsequent 
varying consequences cost the United Kingdom (UK) National Health Service (NHS) 
approximately £8.9 billion each year, which equates to 5% of the total NHS expenditure 2. With 
the prevalence of stroke increasing 3, 4, the pressure to find new methods of supporting stroke 
survivors in their recovery and subsequent quality of life is mounting.   
Systematic Literature Review (Paper 1) 
 
 The aim of the review was to examine the effects and where possible the effectiveness 
of third-wave psychological interventions on the experience of emotional distress following 
stroke. Third-wave therapies are part of an emerging evidence base in psychological research 
with participants who experience chronic health difficulties 5. Given that stoke can lead to 
chronic and persistent difficulties, third-wave approaches within this group warranted further 
investigation. Moreover, third-wave approaches are argued to be trans-diagnostic as they tend to 
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focus on quality of life rather than symptom reduction. These approaches therefore may be 
beneficial to people who experience a range of emotional difficulties post-stroke.  
Previous reviews of interventions targeting emotional distress in stroke have been limited to 
cognitive behavioural therapy interventions (CBT), mindfulness only interventions, or 
medication-based treatment options. Therefore, a systematic review was warranted to examine 
the effects of third-wave approaches.  Ten articles were identified and all were systematically 
appraised.  Overall, the included studies demonstrated the positive impact of third-wave 
approaches in supporting individuals with experiences of emotional distress following stroke.  
However, existing evidence was weak-to-moderate in quality.  Due to the emerging nature of 
the research, most studies in the review were cohort or case study design.  The need for better 
quality research as well as the development of an adequate and sensitive measure of distress 
was highlighted.  
Empirical Paper (Paper 2) 
 
 Paper two examined the relationship between sleep parameters and their temporal 
relationship with participation in activities of rehabilitation in a hospital based acute stroke 
setting. A longitudinal analysis was employed using actigraphy and daily measurements of pain, 
mood and participation over a period of between 3-15 days and nights.  The findings indicated 
that decreased mood predicted lower levels of participation. This association remained significant 
after controlling for baseline mood scores, as well as pain and sleep. Findings also showed that 
there was a significant relationship between increased experiences of pain and improved rate of 
participation. A relationship between poor sleep efficiency (SE) and lower levels of participation 
in rehabilitation was found. However, once mood and pain were considered in the model 
alongside SE, only pain and mood were found to significantly and independently predict 
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participation. Mood should be considered a key target for therapeutic intervention as participation 
in rehabilitation has been linked with improved rates of functional recovery. Moreover, this 
recommendation is directly related to the Mental Health Strategy for England, policy, ‘There is 
no Health without Mental Health’ (2011) 6.    
The assessment of emotional/psychological distress following stroke 
 
Throughout the process of this thesis, both in topic selection (empirical and systematic 
review papers), and research design, the issue of how best to measure and quantify the distress 
experienced by individuals following stroke has been challenging.  One of the major challenges 
was deciding which measure of emotional distress would be most suitable for the target 
population.  Currently there is a scarcity of validated tools available for this purpose, and 
certainly this was even more apparent when brevity of the measure was also an important 
factor.  
For the empirical study aspect of this thesis, two measures of mood were utilised. The 
Hospital Anxiety and Depression Scale (HADS) 7, as a baseline mood measure and the Revised 
Visual Analogue Mood Scale – sad item (VAMS-R) 8, as the daily measure of mood.  The 
empirical evidence currently available suggests that both of these measures are reliable and 
valid in a post-stroke population, however, the author acknowledges that despite empirical 
evidence, these measures are not without their flaws. The chosen measures did not allow 
participants to identify their distress across the range of the emotional experiences, instead 
considering only the constructs of anxiety and depression.  In this respect the author was subject 
to the same limitations as were the studies included in the systematic review (paper 1).  The 
lack of a well-designed and validated measure of emotional distress, which is not narrowly 
defined by psychiatric diagnosis, has resulted in researchers falling into the trap of measuring 
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experiences of distress within the diagnostic category of anxiety and depression. This 
categorical choice is then forced upon participants involved with research. It is possible that 
when individuals are provided with limited options by which to quantify their distress that they 
will either choose the best fit option, or perhaps will not indicate their distress at all. 
Measuring emotional distress within the constraints of the restrictive constructs of 
anxiety or depression is not without its controversies. An example of this is that the prevalence 
rates for post stroke depression (PSD) and post stroke anxiety (PSA) vary considerably within 
the literature with estimates ranging from 10.6-31.1% 9.  Although these categories are 
established to increase internal validity there is still variability as to how they are 
operationalised.  One possible reason for this variance is due to how PSD and PSA are 
conceptualised and assessed, be that with measures based on diagnostic criteria such as the fifth 
edition of the Diagnostic and Statistical Manual of Mental Disorders 10 or the tenth edition of 
the International Classification of Diseases 11, or through structured clinical interviews. Ayerbe 
and colleagues (2014) 12 argue that studies using measures to assess for the presence of mood 
difficulty may overestimate the prevalence in comparison to clinical interviews. One possible 
explanation for this is that the psychometric scales may not be nuanced enough to account for 
the range of emotional expression following a traumatic event such as stroke. Distress can 
therefore be recorded as either an experience of depression or anxiety when it is possible that 
the individual is actually experiencing a range of emotions that fall in the sub-clinical level and 
are likely to resolve without additional intervention.  Additionally, the measurement of PSD is 
not consistent across the literature with different self-rating scales being used to identify its 
presence 13.   
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A further possible implication for the way distress is currently measured in the post-
stroke population is that we remain unclear as to what the actual experiences are for individuals.  
That is, we do not know which aspects of the post-stroke emotional sequelae are causing the 
individual the most distress. Without knowing whether a person needs support with anger, 
sadness, frustration, shame, or loss, it will be very difficult for current interventions to target the 
most pertinent emotional difficulties. Moreover, it is likely that a person is not just experiencing 
one emotion in relation to their experience of stroke, but rather they are dealing with a range of 
emotions, and that it is the compounded effect of these experiences that causes the distress.  
There is a danger that by not engaging with this range of emotional responses in 
research and by pathologizing them as either anxiety of depression, that we are perpetuating the 
problematic narrative that emotional distress is not a normal part of the human experience.  In 
doing so we are locating the problem within the person, rather than normalising their experience 
of distress as a common and understandable response to this traumatic life event.   
In summary, there is a need for a more nuanced and suitable measure of emotional 
distress to be developed; one which can encompass the full spectrum of emotional responses 
and can offer a shared language for both the client and the clinician to be able to talk about the 
subtleties of their emotional experience, rather than this experience being separated into specific 
categories.  This measure is needed so that individuals may have a meaningful way to identify 
their emotional experiences as well as to support the move towards an acceptance of distress as 
a common experience rather than an abnormal reaction.  The measure would also allow 
clinicians to be able to distinguish when patients need the additional support of interventions 
and to then be able to target these interventions successfully.  
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Sleep in an acute hospital setting – opportunities for change 
 
 Throughout the process of data collection, the researcher kept a reflective research diary, 
which included notes from the daily interactions with participants and details of more 
qualitative accounts of their experiences of sleep. This qualitative information may provide 
some context for the rate of sleep efficiency (SE) in this sample being 65% which is 
representative of poor sleep across the sample 14.  Participants in this study largely reflected on 
how they had slept poorly the night before, indicating that they had woken up several times in 
the night, or that they had struggled to fall asleep despite the lateness of the hour. The most 
common reasons provided by participants were environmental in nature, with the most 
discussed reason for poor sleep being noise on the ward.  This is in keeping with previous 
literature considering hospital sleep environments 15, 16.  Noise disruption was a consistent 
complaint irrespective of whether participants were in a side room or on a shared ward. 
However, the reasons for the noise disruption were notably different. Participants on a shared 
ward noted that noise disruption was due to the medical needs of other patients, such as the 
need for a respirator or pain relief throughout the night. Additionally, patients who needed 
attention would press the nurse call alarm and this would sound until a nurse arrived.  Some 
participants complained of other patients talking or snoring loudly in their sleep as being a 
reason of the night time disruption.   
For participants in the single side rooms, they described that noise disruption was due to 
human traffic in the corridor, as well as staff talking with each other and conducting handovers. 
These participants noted that although they were in a side room, they were not able to close the 
door as staff required assess for continued observation.  This is interesting to note given that 
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modern hospital deigns are showing a preference towards single occupancy 17 rooms rather than 
wards. This move is already somewhat controversial 18 given the increased demand on staff 
teams to provide continuous care in a fragmented setting, as well as patients experience of 
loneliness without the companionship of other patients 19. Future research into sleep in a 
hospital environment should investigate the possible differences between ward-based and 
single-room based experiences of sleep.  
The second most commonly reported reason for sleep disruption was the ward-imposed 
sleep opportunity window.  Sleep on the ward is often dependant on staff hand over in terms of 
the transition between night staff and day staff, as well as how quickly staff are able to conduct 
the nightly check on patients, for both physical observations as well as the dispensing of 
medication. Staff reported that this was often the result of staffing issues, for example, if there 
had been an incident during the day, then staff were running behind in the evening, resulting in 
patients often being woken from their sleep-in order to take medications. Moreover, with day 
staff usually commencing their shift at 6am, medication was dispensed to patients shortly after 
this time, which required patients being awoken in order to take medication.  Often participants 
described this process of being woken up to be most disruptive, resulting in an increased 
difficulty with re-establishing sleep once the medication had been taken.  This is not surprising 
given what we know of sleep architecture 20, which indicates that rapid eye movement (REM) 
sleep tends to occur in the early hours of the morning or in the later stages of sleep.  REM sleep 
has been found to support memory consolidation and the development of neural pathways of 
new learning and these processes will be especially relevant in the context of cognitive 
rehabilitation 21, 22. This sleep disruption due to ward-based staffing patterns warrants further 
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investigation, in terms of both the impact of the disruption, as well as exploring the opportunity 
of using a sleep-hygiene informed approach when staffing the wards. 
Finally, the third most commonly reported reason for sleep disruption was lighting.  
Many of the participants reported that they found it difficult to sleep at night due to the lighting 
on the ward, and although this lighting was dimmed or switched off at night, staff often needed 
to switch it back on again when they were carrying out observations on patients. These findings 
are in line with previous research which suggests that lighting alone is not a significant factor of 
poor sleep, but rather it is the combination of lights being switched on to facilitate the process 
of patient monitoring that is disruptive 23. This process of around-the-clock care is clearly 
necessary in an acute hospital setting. however, the consequence of sleep disruption and the 
possible longer-term implications on recovery and participation in rehabilitation require further 
investigation.  
Role of clinical psychologists in an acute clinical setting 
 
  Conducting research on an acute stroke rehabilitation ward was both insightful and 
challenging for a number of reasons.  Often the needs of the patients on the wards were 
complex and susceptible to rapid change in terms of treatment and condition.  Ward staff 
invariably have a series of complex and time-consuming tasks to juggle in providing care to 
their patients and understandably, physical health needs often supersede psychological 
wellbeing.  One suggested reason for this is that professionals may have some difficulty in 
recognising the symptoms of mood difficulties due to the nature of stroke and the subsequent 
hospitalisation 24. Additionally, at times staff can feel overwhelmed and underequipped to deal 
with the emotional distress of patients 25. This distress is then viewed as a role for psychological 
or medical intervention, when perhaps a human connection of empathy and sitting alongside the 
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patient may be most beneficial 26. For this reason, it is especially important for clinical 
psychologists to support the ward staff to feel equipped to work with emotional distress.  
Additionally, working in an acute medical setting can be personally demanding for staff, 
involving working long hours and various shift patterns. Furthermore, as patients are often very 
unwell in an acute setting the experience of loss is likely to be more frequent, which in turn will 
increase the emotional burden placed on staff, both by supporting family members as well as 
the possible interaction with their own life experiences. Consequently, experiences of vicarious 
trauma, and compassion fatigue are common 27, 28. Clinical psychologists are uniquely placed to 
work in this area given the complexity of issues that may present on a stroke or stroke rehab 
ward, being able to provide support to both staff and patients.  This can be done by taking an 
overview of the reciprocal relationship between the distress of patients and the emotional 
burden to the staff team and offering both consultation about patients as well as supervision to 
the ward staff. 
Experience Sampling method.  
 
 A review of the existing literature highlighted the need for better quality research 
considering the possible role of sleep and mood on participation in rehabilitation.  The 
application of experience sampling (ES) has increased rapidly over the last fifteen years 29. ES 
allows for the exploration of relationships between variables and has high ecological validity. It 
facilitates the exploration of subjective experiences, whilst minimising recall bias 30.  The 
experience sampling method utilised in this research facilitated the examination of the link 
between sleep, mood and participation in rehabilitation in ‘real-time’.  
 Prior to engaging in the research, the author considered several options for data 
collection. The number of times the participants were required to provide ratings of their pain 
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and mood was a significant consideration that was discussed in supervision with the research 
team. The possible burden on the participants as well as that on the staff team were considered 
at length.  Prior to recruitment it was noted that the general demographics of the post-stroke 
population were adults over the age of 65 who may be experiencing some level of cognitive 
difficulty 31. Taking into account recommendations for research with older people 32, it was 
decided that the daily measures would be conducted by a researcher with the participants once 
per day.  This would reduce the cognitive load on the participants in terms of the number of 
ratings and the necessity to remember to note their experiences of mood and pain.  Given the 
often complex and busy working environment outlined above, it was also decided that the 
author, would endeavour to collect the daily measures of mood and pain herself, rather than 
adding additional tasks to the nursing staff who were already under pressure.  Although this 
method of data collection was successful in terms of the low rate of missing data across the 
study, it was at times a challenging task to juggle alongside placement and teaching 
commitments. While these data collections methods were acceptable for this exploratory study 
it may be that for larger studies that the experience sampling aspect of investigation could be 
incorporated into the daily checks of the nursing staff in terms of patient observations. This 
would potentially allow for data to be collected over a longer period of time, which may 
provide additional opportunity for analysis in terms of the possible links between sleep, mood 
and pain in a post-stroke population.   
Personal reflections on the research process 
 
Designing and executing an experience sampling study was a substantial challenge 
alongside other doctoral training duties, however, the author believes this has resulted in novel 
and interesting research paper.  The research process enabled the author to develop new skills 
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using the statistical packages SPSS and R.  Although at times this process felt overwhelming, it 
allowed the author to reflect on the importance of seeking supervision in order to scaffold new 
learning and perspective.  The author’s personal understanding of sleep, mood, pain and the 
impacts of stroke has grown substantially throughout the research process, which will 
undoubtedly inform their clinical work.   
Conclusion 
 
In summary, the author’s wider reflections on the issues covered in this critical appraisal 
have resulted in several key conclusions. Firstly, the importance of finding a method of 
understanding individuals’ experience of emotional distress is essential to the future 
development and evaluation of psychological interventions. A second, but equally important 
function of this measure will be to provide patients with a language around their experiences of 
distress, rather than current process of a forced choice between anxiety and depression. This 
language will assist the shared process of understanding between patients and clinical staff, 
allowing both staff and patients to tolerate the distress within the context of common and 
understandable human emotions.  Secondly, while the role of sleep in an acute hospital setting 
and its possible impact on patients’ ability or desire to participate in their rehabilitation 
activities requires further exploration, it is clear that sleep disruption plays an important role in 
patient wellbeing.  
Finally, it is important to note that qualitative investigation of patient’s experiences may 
provide a guide to clinical services on where best to intervene for maximum impact in terms of 
sleep promotion.  
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Stroke impacts approximately 17 million people worldwide each year (Feigin, 
Forouzanfar, & Krishnamurthi, 2014) and one person every five minutes in the UK alone 
(stroke Association, 2016).  As prevalence rates of strokes increase (16.2 million survivors 
worldwide, representing a 68% increase since 1990) (Feigin et al., 2014) so too does our 
knowledge of how to treat people who have experienced stroke. As a result of increased 
survival rates (Hackett, Köhler, O'Brien, 2014), we have seen increasingly more people 
and their families live with the long terms consequences of stroke, such as physical 
disability, cognitive impairment, psychological problems such as anxiety and depression as 
well as fatigue (Wolfe et al., 2011).   The number of people experiencing a stroke is 
growing due to lifestyle implications such as an increase in diabetes and obesity 
(Krishnamurth et al., 2013) as well as, in part the number of people living to old age 
(Wang, Rudd, & Wolfe, 2013).  
Recovery pathways following stroke have been widely researched and investigated 
(Betani, Melegari, De Cola, Bramanti & Calabro, 2017; Jin, Guo, Zhang, & Chen, 2017). 
Recovery from stoke relies on a number of individualistic factors such as a person’s age, 
weight, location of stroke and size of the lesion. However, a recent meta-analysis by 
Bindawas, Vennu & Moftah (2017) concluded that following engagement with 
rehabilitation activities, patients had an overall higher functional capacity (as well as being 
discharged from hospital earlier. As such it appears that increasing a patient’s ability to 
engage with activities of rehabilitation will in turn have a positive effect on recovery 
levels.  
There are a number of factors that impact on a person’s ability to engage with 
rehabilitation activities following a stroke: communication difficulties; cognitive 
impairment; fatigue, sleep difficulties and mood (Plant, Tyson, Kirk & Parsons, 2016). 
This study will attempt to look at the impact of two of these factors mood and sleep.  
Alongside functional capacity mood has been reported to be one of the main factors which 
contribute to health-related quality of life for people who have experienced stroke 
(Almborg, Ulander, Thuline, & Berg, 2010). Indeed, Gray et al. (2011) found an increase 
in the number of people experiencing mental health difficulties in the stroke population, 
including both survivors of stroke and their carer’s. Prevalence rates of mood difficulties in 
the post stroke population are as high as 40-50% in the 12 months following stroke (Creed, 
Swanwick, & O’Neill, 2004).  Individuals who experience mood difficulties following 
stroke also report poor outcomes in terms of recovery, participation in rehabilitation, 
quality of life and indeed mortality (Parikh, Robinson, Lipsey, 1990; Williams, Ghose & 
Swindle, 2004).  
In addition to mood difficulties, studies have also reported that poor sleep can have a 
negative impact on the recovery levels of the stroke survivor. For example, reduced sleep 
may impact as many as 50% of stroke patients (Hermann & Bassetti, 2016).  Sleep 
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disturbances have been strongly correlated with experiences of depression and anxiety both 
in the post stroke population as well as healthy control groups (Naess, Lunde, Brogger, & 
WajeAndreassen, 2012; Leppavuuori et al., 2002).  Poor sleep is also correlated with 
reports of poor life satisfaction, and post stroke recovery and rehabilitation activities 
(Hermann & Bassetti, 2009; 2016; Siengsukon & Boyd, 2008). Current research on the 
relationship between sleep and stroke, indicates that the main sleep variables involved in 
impaired sleep are: poor sleep efficiency (Siccoli & Bassetti, 2008); sleep fragmentation 
(Terzoudi et al., 2009) and insomnia (Sieminski, Gojska, Nitka-Sieminska, & Nyka, 2006).      
Studies that have examined the impact of sleep on next day functioning in healthy controls 
found that poor sleep had a negative impact on functioning (Walker, 2008) this affect 
would most likely be exacerbated in stroke survivors due to possible impairments in both 
cognitive and physical functioning. Together with the findings outlined above this 
highlights the important role of sleep in the post stroke population, and their ability to 
engage in rehabilitation activities.  Sleep remains an unknown factor within the stoke 
population, as example of this the UK National Institute of Clinical Excellence recently 
published guidance on stroke care, the guidance accounts for medical, physical, and 
psychological needs of the patients but makes no reference to sleep (NICE, 2013).  
As outlined above research has shown that there are clear links between poor sleep and 
engagement with rehabilitation, as well as links between low mood and engagement in the 
stroke population. However, as far as we know to date there has been no research 
conducted into the impact of sleep or mood and the effect t that this may have on a 
persons’ ability to engage with rehabilitation activities, within a stoke population. A 
surprising finding, considering the clear links observed between sleep and mood out with 
the stroke population (Ptaoek, Ying-Hui, & Krystal, 2016; Talbot et al., 2012; Wong et al., 
2012).   
There remains a lack of experimental investigation into the possible relationship between 
sleep and mood on participation in rehabilitation activities. Previous methodological 
limitations mean that as yet we have not been able to make a clear distinction on the 
direction of the main effect (sleep or mood). As such further investigation into this area is 
required.   
This study will be an experimental, longitudinal design which will make use of prospective 
measures of sleep, mood, and participation in activities of rehabilitation. We will be 
measuring the temporal relationships between variables over time, which is a novel 
approach given that research in this area is dominated by cross- sectional designs. We aim 
to explore the effect that both (sleep and mood) may have on engagement with 
rehabilitation.  
Identifying dynamic mechanisms of both sleep and mood in the post stroke population may 
lead to more specific therapeutic interventions (Robinson & Jorge, 2016) allowing for a 
targeted approach to recovery-based rehabilitation activities.   
 




Participants who have experienced stroke will be recruited from the Acute Stroke Unit 
within XXXXXXXXXXXXe Hospital as part University Hospitals of South Manchester 
Trust, which provides specialist care to patients who have experienced stroke in the greater 
Manchester area.  
Details of power calculation:  
Using guidance from other ESM studies, we plan to recruit 20 individuals. Therefore, the 
study could potentially yield 140 sets of data. For the regression, we will have 1 variable as 
a predictor (sleep score) and 3 variables held as covariates (see statistical procedure). With 
4 variables, a data size of 84 would be sufficient to yield a power of around 0.8. As we 
cannot predict the degree of missing data or participant drop-out rates, we believe a sample 
of 20 will ensure that at least 84 data sets are gathered to explore our hypotheses 
All participants will have experienced a stroke (ischaemic or haemorrhagic) and will have 
been admitted onto the acute stroke ward, patients will have been on the ward for a 
minimum of 48 hours prior to being approached about the research.  All participants will 
be expected to remain on the stroke ward for the duration of data collection; this can be 
between 3-15 days depending on the length of stay on the ward. Participants are required to 
have a command of the English language that will be sufficient to complete assessments 
and provide informed consent for participation. Participants will need to be fully conscious 
or able to awaken to fully consciousness during all assessments for the research. 
Participants are required to be orientated to time (year) and place Participants will also be 
aged 18 or over and will not have any significant issues with mobility that would inhibit 
the use of the actigraph watch (mobility will be assessed by a Physiotherapist). Participants 
will also not have a previous or existing diagnosis of sleep apnoea.  
Design 
This study will collect quantitative data.  
Individuals who have experienced a stroke 
The primary outcome measures will be sleep, mood and level of participation in 
rehabilitation activities. The mood measure will be administered once per day for the 
number of days that the participant is active in the study (between 3-15 days). Sleep will be 
measured using actigraphy, each participant will wear an actigraph watch on their most 
mobile wrist (assessed by physio) for the period they are participating in the study 
(between 3-15 days).  
A possible confounder in the data may be the participants experience of pain, and the 
impact that this pain may have on their ability to participate in rehabilitation activities. As 
a result, a daily measure of pain will be administered. 
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Baseline outcome measures for mood and pain will be administered prior to the study. In 
addition to this descriptive characteristics of the participants will be gathered from their 
medical record, these will include:  
• Age 
• Sex 
• Time since stroke 
• Location of lesion 
• Side of deficit 
• Size of lesion 
• Barthel index 
• Medication 
• Co-morbid medical conditions 
Participation in rehabilitation will be measured using an objective measure completed by 
clinical staff who conduct the rehabilitation activity.  
Materials 
The following questionnaire measures will be used: 
 Baseline measures: 
Mood 
Hospital Anxiety and Depression Scale  
The HADS is a validated, widely-used, 14-item self-report scale designed to briefly 
measure current anxiety and depressive symptoms in non-psychiatric hospital patients 
(Zigmond & Snaith, 1983). It excludes somatic symptoms, therefore avoiding potential 
confounding factors. The HADS comprises two independent seven-item subscales for 
anxiety and depression. The HADS has been normed and validated within the stroke 
population and demonstrated useful application as an acceptable screening instrument 
(Sagen et al., 2009).  
Depression Identity Scale Circles 
For participants who wish to participate but are experiencing aphasia, mood will be 
assessed using the Depression Identity Scale Circles (DISCS).  This instrument was 
developed within the context of brain injury setting, as has been validated within an 
aphasia population (Turner-Stokes, Kalmus, Harani, & Clegg, 2005).  
Visual Anxiety Measure 
For participants where it has been established that Aphasia is present then we will use the 
Behavioural outcomes of anxiety scale to measure anxiety (Adams, Morris & Kneeborn, 
2015. BOA). This measure has been validated within the stroke population, and is a 
observational measure of anxiety, which can be completed by a family member or carer for 
the participant.   
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Pain 
Numerical pain rating scale supplemented with the Faces pain scale - NPRS-FPS 
The NPRS-FPS is a validated and reliable measure of pain in people with stroke, with good 
relative and absolute reliability (Chuang, Wu, Lin & Hsieh, 2014). Pain is a relevant 
variable to measure as it has been shown to impact both on mood and social engagement 
within a stroke population (Almenkerk et al., 2015).  
Cognitive Impairment 
Montreal Cognitive Assessment – MoCA (Nasreddine et al., 2005) 
The MoCA contains items which assess stroke-relevant domains and has been shown to 
have good sensitivity in detecting global impairment (Blackburn, Bafadhel & Randall, 
2013). For participants who have been identified as aphasic the Oxford Cognitive Scale 
(OCS) will be used to assess cognition. This scale has been validated against an aphasic 
population (Demeyere et al., 2015). These are currently routine measures on the ward so 
data may be pre-existing. Where this is not the case a MoCA or an OCS assessment will be 
carried out by the researcher. This measure is within the competencies of the Trainee 
Clinical Psychologist (principle investigator), further to this field supervisor Dr Viki 
Teggart will offer supervision for this measure.  Where the participant’s communication 
difficulties significantly inhibit a cognitive assessment then they will no longer be able to 




Objective measurement of sleep-wake patterns will be conducted using wrist actigraphy 
over a period of between 3-15 days and nights, utilising an epoch of thirty seconds (i.e. 
categorisation of movements will occur every 30 seconds).  Actigraphy provides a 
recording of continuous motor activity and has been validated for use within the stroke 
population Cavalcanti et al., 2013). Three sleep variables will be extracted from actigraphy 
data: sleep efficiency (SE), sleep onset latency (SOL), and wake after sleep onset (WASO).  
These variables have been selected as they have been identified by previous research to be 
the most impaired functions following stoke (e.g. Siccoli et al., 2008; Bakken et al., 2012; 
Terzoudi et al., 2009).  
 
Mood 
Visual Analogue Mood Scale -Revised (VAMS-R) will be administered to participants by 
the researcher once per day during the time they are wearing the actigraph The VAMS is a 
reliable and valid measure of eight specific mood states: (Afraid, Confused, Sad, Angry, 
Energetic, Tired, Happy, and Tense), although we are interested in the ‘sad’ mood 
construct for this research design, the measure results in eight scores between 0-100. It 
places minimal cognitive or linguistic demands on the respondent and is appropriate for 
neurologically impaired individuals (Kontou, Thomas & Lincoln, 2012). The VAMS has 
 ETHICS                                                                                                                     4—62 
 
been normed against 425 healthy adults and 290 psychiatric inpatients and outpatients and 




A daily measure of pain will be administered to participants, this will allow researchers to 
control for this variable within the model. We will use the same measure as outlined above 




The Pittsburgh Rehabilitation Participation Scale (PRPS)  
The scale will be completed by clinicians following rehabilitation sessions with the 
participants, a scale can be completed following each session and takes less than 5 minutes 
to complete. The PRPS is a clinician-rated 6-point Likert-type item measuring patient 
participation in inpatient rehabilitation sessions. The PRPS has been validated and normed 
against a stroke population and has been shown to collate with functional outcomes for 
patients (Lenze at al., 2002). A mean score of the six items will be calculated from the total 
PRPS scores for each participant, it will be this score that is used as the daily score.  
 
Procedure 
Roles of the research team in the procedure 
Leona Rose will be involved in the recruitment (taking consent) and data collection with 
participants (daily measures of mood and pain) and will be involved in the data analysis.  
Dr Viki Teggart may be involved in the recruitment (taking consent) and data collection 
(mood and pain) and will be involved in the data analysis.  
In addition, an assistant psychologist and research practitioner who hold positions with 
XXXXXXXXXXXXe Hospital and University Hospital of South Manchester Trust 
(UHSM) may be involved in recruitment and data collection.  
Dr Lee Mulligan and Dr Gullimero Perez Algorta will both be involved in the data 
analysis.  
Clinicians involved in rehabilitation will complete the objective rehabilitation participation 
questionnaire following each rehabilitation session that a participant is scheduled to 
complete for the duration of the participants involvement in the research study.  
 
Recruitment 
Participants will be recruited and identified by the participant information centre (PIC): 
XXXXXXXXXXXXe Hospital.  
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Procedure at XXXXXXXXXXXXe 
A briefing will be provided to all clinical staff who work on the stroke ward at 
XXXXXXXXXXXXe Hospital regarding the study.  
Participants who have experienced a stroke and who have been admitted onto the Stroke 
ward will be recruited and identified by a members of the research team who have honary 
contacts with UHSM NHS Trust, and by health professionals in their care team,  team who 
are based on the Stroke Ward at XXXXXXXXXXXX Hospital.  
All staff will be briefed by Leona Rose (trainee clinical psychologist) and Dr Viki Teggart 
(clinical neuropsychologist). The staff will identify whether a patient who has been 
admitted onto the ward meets the inclusion criteria and if so, the patient will be approached 
by Leona Rose or Viki Teggart to give the patients information on the research. 
Participants will be given  the participant information sheet (appendix A). These 
participants will indicate their consent to be contacted again by a member of research team 
at a later date once they have had an opportunity to consider the information.  
Each participant will then be followed up by a member of the research team Leona Rose or 
Dr Viki Teggart who is based on site at XXXXXXXXXXXXe Hospital.  Participants will 
be provided with information about the study and will have the opportunity to ask any 
questions. During this process the participant is welcome to have a friend or family 
member present; this will be made clear to the participant.  
If the participants are still interested in taking part then either Leona Rose or Dr Viki 
Teggart will check once again that the participant understands the information given in the 
relevant participant information sheet and then the researcher will take written consent 
(appendix B). Once consent has been provided, the initial (baseline) questionnaires will be 
completed (this will be paper based). This gives the participants an opportunity to ask any 
questions about the study or the questionnaires.  In addition, participants will be given an 
actigraph watch to wear on their most mobile arm for the duration of their involvement in 
the study.   
A letter will be send to the GP of the participant ( unless the participant has expressed a 
wish for this not to happen) with a copy sent to their treating clinician to inform them that 
their patient is taking part in the research (appendix).  
Those clinical staff involved in the rehabilitation activities for the participants will be given 
details by the principle investigator Leona Rose about the Pittsburgh Rehabilitation 
Participation Scale (PRPS), including guidance on its completion. They will have an 
opportunity to ask any questions during the briefing as well as having access to a member 
of the research team who is based on site at XXXXXXXXXXXXe Hospital. Clinical staff 
will be informed of which patients are participating in the research to ensure they are able 
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The baseline questionnaire measures will be administered immediately after taking consent 
(see recruitment section above). The daily questionnaire measures will be completed with 
the participant by a member of the research team, these measures will take no longer than 5 
minutes to complete. The daily measures of rehabilitation engagement will be completed 
by the clinicians involved in the participants rehabilitation activities. This questionnaire 
measure will take no longer than 5 minutes to complete.   
Actigraph 
The actigraph watch will be assigned to the participant following consultation with physio 
colleagues about which arm (left or right) is the most mobile. The watch will be given to 
participants following consent and will be worn by them for the remainder of the research, 
this could be between 3-15 days.  
Analysis 
Quantitative Analysis 
Descriptive data on the participants will be assessed and tabulated. Scaled data will be 
checked for normality and other parametric data assumptions and, where necessary 
transformed. Statistical analysis will be performed using SAS version 9.4. As the ESM measures 
have a 3-level hierarchical structure (entry points nested within days nested within participant) 
we will use multilevel modelling in the analysis to account for the clustering in outcomes within 
participants.  We will calculate summary statistics (mean and variability) of participation for each 
day. In order to test the hypotheses of this study, and to take into account the nested nature of 
the data, two multilevel models for discrete outcomes will be generated, with sleep and mood as 
the independent (predictor) variables in the separate models, participation in rehabilitation 
activities will form the dependant variable. To account for possible confounding, we will include 
baseline measures of anxiety, depression, and pain as additional covariates in all the models. 
  
Dissemination 
These findings will be presents t the medical team within XXXXXXXXXXXX Hospital 
and fed back to patients and support groups via formal and informal presentations. The 
data will also be published in relevant journals such as Stroke and Clinical 
Neuropsychology.   Participants will also receive a copy of the findings if they request this.  
Practical Issues 
Permissions for use of copyrighted scales has been sought where necessary. The licences 
for all the necessary statistical analyses are already available through Lancaster University.  
Ethical concerns 
Risk to participants 
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This research is aimed at understanding the possible relationship between and sleep and 
mood and the impact that this may have on a patient’s ability to take part in rehabilitation 
activities following stroke. It is not anticipated to cause any distress to participants. 
However all members of the research team will use their clinical expertise to address this 
appropriately should distress arise during the course of the study.  
If any of the research team become concerned that a participant poses a risk of serious 
harm (to themselves or others) they will inform the treating clinician who will access if any 
further intervention is necessary.  
Participants will also be given advice on the participant information sheet about who to 
contact if they are experiencing distress.  
Risk to researchers 
The researcher will not be alone with a participant on any occasion, as the research is due 
to be conducted at the patient’s bedside while they are an inpatient on the ward.  All 
research will be conducted within XXXXXXXXXXXXe hospital. The research team will 
adhere to the health and safety policies of the research site.   
Timeline for study competition.  
Submit ethics proposal: April 2017 
Data collection: Sep - Dec 2017 
Data analysis: Dec 17 - Jan 18 
Comment on first draft of literature review: Oct 2017 
Comment on first draft of research paper: Dec 2017 
Comment on second draft of literature review: Jan 2018 
Comment on second draft of research paper: Feb 2018 
Comment on first draft of critical review: March 2018 
Comment on second draft of critical review: April 2018 
Submit thesis: May 2018 
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An examination of sleep and mood on predicting participation in rehabilitation activities 
in an inpatient stroke population.  
 
We are asking if you would like to take part in a research study to investigate whether sleep 
and mood have an impact on a person’s ability to engage with rehabilitation activities 
during an impatient hospital stay following a stroke. 
 
Before you consent to participating in the study we ask that you read the participant 
information sheet and mark each box below with a tick if you agree.  If you have any 
questions or queries before signing the consent form please speak to a member of the 
research team.  
 




1. I confirm that I have read the participant information sheet and fully 
understand what is expected of me within this study  
 
2. I confirm that I have had the opportunity to ask any questions and to 
have them answered.  
 
3. I understand that my participation is voluntary and that I am free to 
withdraw at any time without giving any reason, without my 
medical care or legal rights being affected. 
 
4. I understand that relevant sections of my medical notes and data 
collected during the study may be looked at by individuals from 
Lancaster University, from regulatory authorities or from the NHS 
Trust where it is relevant to my taking part in the research. I give 
permission for these individuals to have access to my records. 
 
5. I agree to the treating clinician at the hospital being informed of my 
participation in the study. 
 
6. I understand that the information from my questionnaires and 
actigraphy data will be pooled with other participants’ responses, 
anonymised and may be published. 
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7. I consent to information from the being used in reports, conferences 
and training events.  
 
8. I understand that any information I give will remain strictly 
confidential to the researchers unless it is thought that there is a risk of 
harm to myself or others, in which case this information may need to 
be shared with appropriate persons. 
 
9. I consent to Lancaster University keeping the data from the study for 
up to 10 years after the study has finished.  
 
10. I consent to take part in the above study.  
 








Consent to contact GP 
 
 Please tick the box if you 
agree with the statement 
11. I agree to my GP being informed of my 
participation in the study 
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 Researcher     
    
 
        Leona Rose 
 
 
Taking  part  in  research  
about  sleep  and  mood  following  stroke.  
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I am happy for Lancaster 
University  to keep my 




























Participant Information Sheet 
 
An examination of sleep and mood on predicting participation in rehabilitation activities in an 
inpatient stroke population.  
My name is Leona Rose, I am a trainee clinical psychologist at Lancaster University. This 
study will form part of my doctoral research and is an academic requirement for my 
course. Myself and my supervising tutors would like to invite you to take part in our 
research study. Before you decide we would like you to understand why the research is 
being done and what it would involve for you. Please feel free to talk to others about the 
study when making up your mind. One of our team will also go through the information 
sheet with you and answer any questions you have before you decide whether you want 
to take part. 
What is the study about? 
When a person experiences a stroke they may be asked to take part in some 
rehabilitation activities such as physiotherapy and speech and language therapy. We 
know that if a person is able to engage with rehabilitation activities that they may have an 
improved rate of recovery compared with those people who find it difficult to engage 
with them. We are interested in what might be getting in the way of a person’s ability to 
take part in rehabilitation sessions. People who have had a stroke often experience some 
difficulties with sleep and mood (feeling sad or frightened). Sometimes issues with sleep 
and mood can make taking part in rehabilitation activities more difficult because you may 
be tired or not feel able.  The aim of this study is to find out if it is sleep or mood that is 
having the biggest impact on a person’s ability to participate in rehabilitation.  
 
Why have I been approached? 
You have been approached because the study is for people who have experienced a 
recent stroke and are being treated on an inpatient ward. We are approaching people 
who are taking part in rehabilitation activities to see if mood or sleep is having an impact 
on their ability to participate.  
 
Do I have to take part? 
No.  It’s completely up to you to decide whether or not you take part. If you decide not to 
take part it will not affect your clinical care in any way. If you agree to take part, you can 
still stop and withdraw at any time without giving a reason.  
 
 
What will I be asked to do if I take part? 
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Opting in 
If you are possibly interested in taking part then first you contact Leona from the research 
team (more details are given at the end of this information sheet) who will tell you more 
about the research. If you are still interested in taking part, a member of the research 
team will come and meet with you at the hospital so you can sign a consent form and you 
will also complete some questionnaires (see below). 
 
 
Collecting information about your sleep and mood 
If you decide to go ahead and participate then we will collect some data from you each 
that you are on the ward for a maximum of 14 days (data collection will stop after 14 days 
even if you remain on the ward).  We want to do this in two ways: by questionnaires and 
using an actigraphy (sleep) watch.  
 
Questionnaires 
We will ask you to complete some questionnaires: before the research starts, and then 
every day you are taking part in the research for a maximum of 14 days.  The 
questionnaires we will complete at before the research starts will take about 30 minutes 
to complete. The questionnaires that we will complete every day will take no longer than 
5 minutes to complete. A researcher will be with you every time you complete a 
questionnaire.  
 
We will also ask the professionals who are completing your rehabilitation sessions with 
you to complete a questionnaire. This will be about their opinion on your ability to engage 




Actigraphy is a non-invasive method of monitoring human rest/activity cycles. A small 
actigraph unit is worn on the wrist for a period of time between 2-15 days to measure 
how you sleep The movements the actigraph (sleep watch) unit undergoes are continually 
recorded.  The data can be later read to a computer and analysed offline. The actigraph 
will not inhibit your movement and you will be able to carry on with your normal 
activities. We will ask you to wear the actigraph (sleep) watch on your wrist with the most 
movement, and you will wear this 24/7 for the length of time you take part in the study 
(between 3-15 days).  
 
Will my data be confidential? 
The information you provide will be kept confidential. The data collected for this study 
will be stored securely and only the researchers conducting this study will have access to 
this data: 
o Hard copies of questionnaires will be kept in a locked cabinet. 
o The files on the computer will be encrypted (that is no-one other than the 
researchers will be able to access them) and the computer itself password protected. 
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o At the end of the study, hard copies of questionnaires and consent forms will be 
kept securely in a locked cabinet for ten years which gives the researchers time to 
analyse all the data and publish it. At the end of this period, they will be destroyed.  
o At the end of the study, electronic questionnaires, the data from the questionnaires 
and actigraph will also be kept securely on the computer for ten years. 
o Your name will not appear on any of the data stored instead you will be assigned a 
number, e.g. participant 1.  
 
If you take part we will write to your GP to let them know that you are taking part unless 
you prefer us not to do this. We will also send a copy of this letter to your treating 
clinician at the hospital so the team there know too. However, this information will only 
say that you are taking part in the study and will not contain any of your questionnaires or 
interview data. 
 
There are some limits to confidentiality. If at any point in the study ( filling in a 
questionnaire or talking to a researcher) you say something that makes us think that you 
or someone else is at significant risk of harm, we will have to break confidentiality and 
speak to your treating clinician or a member of the team at the hospital. .  If possible, we 
will tell you if we have to do this.  
 
 
What will happen if I decide to leave part way through? 
You can choose to stop participating in the study at any time. If you leave the study, we 
will keep the data (questionnaires and actigraphy data) that you have already given us, 
unless you ask us to destroy them. If you ask us to withdraw your data at any point, every 
effort will be made to do so, but it may not be possible if your data has been fully 
anonymised and have already been analysed.  
 
This will not change the usual clinical care that you receive.  
 
What will happen to the results? 
The results will be summarised and reported at conferences and local groups and will be 
submitted for publication in academic and/or professional journals. If you would like a 
copy of the results, please ask the researchers. The results will also form part of a 
research project for a doctorate in clinical psychology at Lancaster University.  
 
 
Are there any risks? 
There are minimal risks anticipated with participating in this study.  If you experience any 
distress during the study, please discuss it with the research team. There will be someone 
from the research team available to you Monday to Friday 9-5.  
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If you experience any distress following participation and do not wish to discuss them 
with a member of the research team you are encouraged to contact the resources 
provided at the end of this sheet.   
 
Are there any benefits to taking part? 
Taking part may highlight some difficulties with your sleep, if so it is possible that some 
targeted guidance can be offered which could improve your care.  
 
 
Who has reviewed the project? 
This study has been approved by the NHS Research Ethics Service, University Hospitals of 
South Manchester Trust and the Research and Development department and Lancaster 
University Research department 
 
 
Where can I obtain further information? How do I opt in? 
If you might be interested in participating in the study, please contact Leona Rose who is 
a trainee clinical psychologist and one of the researchers. You can do this by email: 
l.magee1@lancaster.ac.uk, by telephone (07715 639 269). You can also let the team at 
the hospital know that you want to take part and they will pass on your details. 
 
Leona will tell you more about the project and then you can decide whether you are 
interested in taking part. 
 
Research team 
This research is led by Leona Rose at Lancaster University. Other members of the team 
are Dr Viki Teggart clinical neuropsychologist at xxxxxxxxxxx Hospital, Manchester, Dr Lee 




If you wish to make a complaint or raise concerns about any aspect of this study and do 
not want to speak to the researchers, you can contact:  
 
Professor Bruce Hollingsworth 







If you would like to make a complaint, and would like to speak with someone outside of 
the Health Research department, please contact:  
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Professor Roger Pickup Tel: +44 (0)1524 593746  
Associate Dean for Research Email: r.pickup@lancaster.ac.uk  
Faculty of Health and Medicine  
(Division of Biomedical and Life Sciences)  








It is not anticipated that taking part in this research will cause distress. However, should 
you feel distressed as a result of taking part you can contact: 
 
Leona who is the lead researcher on this project on 07715 639 269 or 
l.magee1@lancaster.ac.uk 
Viki from the research team on 0161 291 6971  
You can also contact a member of your clinical care team at the hospital or your GP.  
 
The following organisations may also provide advice or support. 
 
Stroke association www.stroke.org. 
There is lots of advice and information on their website. If you call the help line on 0303 
3033 100, they can offer specialist support and advice. More information about this 
service and about finding support in your local area is given here: 
https://www.stroke.org.uk/finding-support  
The Samaritans  www.samaritans.org 
The Samaritans offer a non-judgemental listening service. Their phone number is 08457 
90 90 90 (charges apply) or you can email them on jo@samaritans.org 
 
Research and more information 
Stroke 





Information about ongoing and previous stroke research can be found here:  
https://www.stroke.org.uk/research  
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We  are  doing  some  research 
 
It  is  about  stroke  and   




Research  helps  us  learn 
 













Your  stroke  may  have  affected  your  sleep 
 
and  your  mood 




You  are  having  treatment  for  your  stroke  in 
xxxxxxxxxx  Hospital 
 
Who is doing the research? 
 
 
       
 
 
      
           
 
 
The  main  researcher  is   
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sometimes  this  can  get  in  the  way  of  your 
















We  don't  know  enough  about  it 
 

























We  want  to  compare  sleep  and  mood 
 
We  want  to  know  which  has  the  biggest  impact  




We  want  20  people  to  take  part  
 
All of  the  people  will  have  the  same  tests   
 
This  will  last  for  a  maximum  of  15  
days 







The  researcher  will  look  at  the  results 
  
They  will  learn  about  what  effects  
You getting better 
 
 







In  the  research  you  will  
 




answer  some  questions   
 
 





We  will  give  you  a  questionnaire  everyday  




        
 










































 We  will  keep  your  information  safe 
 
 






The  research  will  happen  in hospital  
 
      
      
 






How long will the research last? 
 
 
The  whole  research  will  last  for  12 months 
 
Your  part  will  last  for  15 days maximum 
























You  can  decide 
 
You  don't  have  to  
 
If  you  don’t  take  part  you  will  still  get  your  
normal  help 
 
 
If  you  change  your  mind,  you  can  stop at  
any  time 
 
 
You  don't  have  to  give  a  reason 













You  don't  have  to  decide  now,  you  can  think  
about  it 
 
You  can  take  your  time 
 
You  can  read  the  information  again 
 





Who will see the information about me? 
 
 
We  will  keep  the  information  about  you  
safe 
 
Only  the  researchers  will  see  the  
information  about  you 
 













We  may  share  your  information  with  other  
researchers  in  this  country 
 
We  may  share  your  information  with  
researchers  in  other  countries 
 
This  helps  with  other  research  about  
stroke 
 
We  will  take  out  your  name  and  
personal  details   
 
We  will  share  this  research  with  Lancaster 
University  as  it  is  part  of  an  
 
 




We  will  tell  your  doctor  that  you  are  in  
this  research  project  
 
  
 ETHICS                                                                                                                     4—90 
 
  




You  may  enjoy  taking  part 
 
 




You  will  help  people  in  the  future 
 
They  will  get  better  help 
 
  
You  will  help  us  to  learn 
 
This  may  support people with  strokes  in  
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You  may  find  it  distressing 
 
 
It  will  take  up  your  time 
 
 






You  will  still  get  your  normal  help 










A  committee  decides  if  research  can  
happen 
 
This  is  the  ethics  committee 
 
They  say  that  this  research  can  happen 
 
They  say  that  it  is  safe 
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What if something goes wrong? 
 This  is  very  unlikely  
 
However,   
 
The  NHS  has  set  up  a  committee   
 
This  committee  will  monitor  the  research  
 
The  committee  has  different  people  from  
















If  you  take  part  in  the  research 
 
and  if  you  think  you  were  harmed 
 
there  are  people  to  talk  to 
 
contact   
Professor Bruce Hollingsworth 
at   
Head  of  Division  of  Health  Research 








Stroke  association  www.stroke.org. 








       
0303 3033 100 
 
The Samaritans   www.samaritans.org 
08457 90 90 90 
jo@samaritans.org 
 
The  University   has  insurance 
  
 
What will happen after the research? 
 
 
The  researchers  will  look  at  the  results 
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What will happen to the results? 
 
 











We  will  share  the  results   
 
with  other  researchers  
 
at  conferences  and  meetings 
 
through  newsletters  and  magazines 
 








The  results  will  not  use  your  name  
 
  






Do  you  want  to  take  part? 
 






You  may  want  more information 
 
Contact   
Leona Rose 
Division  of  Heath  Research 





They  will  answer  your  questions 
 
Let  us  know  if  you  want  to  take  part 
 
You  can  contact  us  at   
Division  of  Heath Research 
















If  you  decide  to  take  part   
 
you  will  need  to  sign  a  consent  form 
 
This  says  that  you  understand  the  research  








We  will  contact  you   
 
 
We  will  ask  for  your  decision 
 
 
Yes  I want  to   
 
 
No  I  don't  want  to 


















If  you  decide  to  take  part  
 
you  will  have  an  appointment   
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Appendices 
Word Count Statement 
 
Thesis word count:  
Thesis Abstract:  245 
Literature Review: 6,736 
Empirical Paper: 6,855 
Critical Appraisal: 3,261 
Ethics Proposal: 3,663 
Total: 20,760 
 
Appendices word count: 
Tables: 2,485 
Figures: 250 




Whole Thesis Document: 42,28 words.
  
 
 
